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Hutchinson-Gilford Progeria Syndrome (HGPS) is an autosomal dominant disorder caused by de novo 
mutations in the gene (LMNA) encoding lamin A that results in “premature aging” and early death.  HGPS 
belongs to a group of disorders collectively referred to as, segmental progeroid syndromes, because 
multiple organs and tissues exhibit premature degenerative phenotypes consistent with physiological 
aging.  The results presented here indicate that HGPS cells exhibit an elevated steady-state level of DNA 
double-stranded breaks (DSBs) and impaired repair of ionizing radiation (IR)-induced DSBs, both of 
which correlate strongly with the nuclear structural irregularities observed in a fraction of HGPS cells.  
These DNA damage-associated defects are due to the presence of Progerin in a dominant gain of 
function manner.  Accordingly, reduction of Progerin levels by treatment with a farnesyl transferase 
inhibitor (FTI) improves repair of IR-induced DSBs.  Interestingly, MRN (MRE11/Rad50/Nbs1) repair 
complex factors, involved in DSB repair, exhibit delayed localization to IR-induced DSBs, which may 
contribute to the repair defect.  Furthermore, many segmental progeroid syndromes including HGPS 
exhibit phenotypes consistent with pre-natal developmental defects.  These developmental defects are 
significant in their own right, but also because they may contribute to the post-natal progressive 
degeneration observed in HGPS.  To begin investigating whether the HGPS mutation has adverse effects 
during pre-natal development, the expression of nuclear lamins was characterized in mouse (mESCs) 
and human (hESCs) embryonic stem cells which have been shown to be representative of pluripotent 
inner mass cells of blastocyst-stage embryos.  This study shows that lamin A is not expressed in 
undifferentiated mESCs and hESCs, but becomes expressed quickly during in vitro hESC differentiation.  
Theses results suggest that Progerin is absent during early pre-natal development, but becomes 
expressed at later stages when the LMNA gene is activated, perhaps adversely affecting the 
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developmental process.   Altogether, theses studies identify impaired DNA DSB repair as a molecular 
mechanism that may contribute to the progressive degeneration phenotype and suggest that at least 
some of the pathophysiology may begin before birth.    
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INTRODUCTION 
 
 
 
1.1 PHYSIOLOGICAL AGING AND DNA DAMAGE 
 
 
Physiological aging is commonly described as a progressive decline in tissue functionality with increased 
mortality and is believed to be caused by a combination of genetic and environmental influences.  
Although multiple theories have been proposed, there is no unified theory for why and how organisms 
age.  At the cellular and molecular levels, progressive decline in tissue functionality is believed to occur in 
large part due to the accumulation of damage to various cellular components and biomolecules that can 
lead to cell loss or loss of function.   The body copes with such continuous damage, maintaining tissue 
homeostasis and function, by recycling cells through regeneration from stem cell pools.  It is believed that 
the physiological decline that defines aging is due to an inability of the body to support regeneration 
indefinitely.  This is the basis for the “Disposable Soma” evolutionary theory of aging which states that 
organisms have evolved to invest only enough energy to regenerate the soma to maintain proper tissue 
function to reach reproductive age, since energy devoted to regeneration of the soma reduces the energy 
devoted to development and reproduction (reviewed in (Kirkwood, 1977; Kirkwood and Holliday, 1979)).  
This hypothesis demands that the optimal level of energy invested in maintenance is below the minimum 
required for immortality (indefinite regeneration) and implies natural rates of tissue deterioration and 
eventual death.  It is important to note that physiological aging and pathological disease are different 
phenomena even though one may contribute to the other.   For example, many disease states such as 
atherosclerosis, cancer, etc…arise preferentially during old age and are believed to be caused at least in 
part by the loss of proper cellular or tissue function.  Alternatively, genetic mutations can lead to diseases 
such as the segmental progeroid that appear to accelerate aging. 
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It is believed that damage to various cellular components, such as nuclear and mitochondrial DNA, RNA, 
and proteins contributes to physiological aging.  However, it is thought that the accumulation of nuclear 
DNA damage is particularly detrimental because cells only have two copies of nuclear DNA, whereas 
several thousand copies of the mitochondrial genome exist and damaged proteins, RNA, and other 
cellular components can be replaced (reviewed in (Lombard et al., 2005)).   Thus, damage to nuclear 
DNA can be particularly harmful to cellular function and survival.  Even repair of nuclear DNA damage via 
the multiple repair mechanisms that exist usually results in changes to the local DNA sequence, 
producing mutations that may have significant consequences for the cell.  There are several lines of 
evidence suggesting a mechanistic link between nuclear DNA damage and physiological aging 
(Reviewed in (Lombard et al., 2005)).  It has been shown that the steady-state level of DSBs increases 
with age and that a higher proportion of radiation-induced DSBs remain unrepaired in cells from older 
individuals (Sedelnikova et al., 2004), which suggests that DSB repair mechanisms become less efficient 
with age.  Similarly, multiple studies have shown that older individuals exhibit a higher mutation frequency 
(Reviewed in (Vijg, 2000)).  Lastly, there is the observation that multiple progeroid syndromes are caused 
by mutations in DNA maintenance proteins and exhibit impaired DNA damage repair (Reviewed in 
(Puzianowska-Kuznicka and Kuznicki, 2005)).  
 
Segmental Progeroid syndromes are a category of diseases characterized by the premature appearance 
of features consistent with physiological aging and early death (Reviewed in (Hofer et al., 2005; Navarro 
et al., 2006; Puzianowska-Kuznicka and Kuznicki, 2005).  Because of the premature appearance of age-
associated features, these diseases have been referred to as “accelerated aging” disorders.  Such 
syndromes are referred to as “segmental” because they affect multiple organs and tissues, although no 
progeroid syndrome affects all organs and tissues, identifying a major difference with physiological aging.  
However, even if these syndromes do not mimic aging in its full extent, the mechanisms responsible for 
the tissue-specific progressive deterioration observed in these syndromes may help us to better 
understand the fundamental mechanisms responsible for physiological aging.   
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1.2. Hutchinson-Gilford Progeria Syndrome 
 
 
HGPS is a rare segmental progeroid syndrome first clinically described by Hutchinson (Hutchinson, 1886) 
and later by Gilford (Gilford, 1904).  It results from de novo mutations in the LMNA gene and has an 
estimated incidence of 1 in 4,000,000.  It is considered the most severe of the progeroid syndromes 
affecting multiple tissues and resulting in a median lifespan of ~13 years.  Until the recent discovery of the 
mutated gene (De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003), diagnosis was based solely on 
clinical features, an approach that current genetic analysis has shown to be imperfect.  Misdiagnoses 
have occurred because segmental progeroid syndromes share many clinical features.  Unfortunately, 
misdiagnoses have resulted in some early research studies on HGPS being performed on cells from 
individuals that since been shown to harbor different mutations.  A clear consensus on the clinical 
features specific to HGPS is important for disease diagnosis, understanding disease progression, and for 
determining success criteria in current clinical trials.  A recent study of HGPS patients harboring the 
correct mutations systematically described a variety of pathological features that patients exhibit 
(Merideth et al., 2008).  This study showed that HGPS patients are characterized by abnormalities that 
may be associated with developmental/growth defects, such a hypodontia (7/11), ankyloglossia (7/14), 
circumoral cyanosis (13/15), ogival palate (8/15), delayed tooth eruption (12/15), and double row of teeth 
(3/15), as well as conditions reminiscent of physiological aging, including, alopecia (15/15), altered skin 
pigment (15/15), and sclerotic skin (12/15) (Merideth et al., 2008).  Individuals afflicted with HGPS exhibit 
growth retardation.  Mean body mass at birth is normal, but falls below the third percentile shortly after 
birth, resulting in an average gain of 0.65kg per year between the ages of two and ten, compared to 1.80 
kg per year for healthy children (Merideth et al., 2008).  Individuals receiving hormone therapy gained 
1.01kg per year (Merideth et al., 2008).  Similarly, height falls below the third percentile for healthy 
children by 15 months of age, resulting in an average gain of 3.58 cm per year compared with 5.84 cm 
per year for healthy children (Merideth et al., 2008).  HGPS patients receiving growth hormone gained 
3.98 cm per year (Merideth et al., 2008).  Contributing to low body mass is decreased bone density and 
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percent body fat (Merideth et al., 2008).   Impaired growth does not appear to be due to inadequate 
nutrition, abnormal growth hormone production, or insulin resistance (Merideth et al., 2008).   HGPS 
patients also exhibit various physical and functional cardiovascular abnormalities, resulting in overall 
reduced vascular function with age.  Particularly, patients exhibit medial smooth-muscle cell loss, 
maladaptive vascular remodeling, intimal thickening, disrupted elastin fibers, deposition of extracellular 
matrix, and stenosis associated with sclerotic plaques in the aortic and coronary arteries (Merideth et al., 
2008).  The cardiovascular irregularities are of particular interest, considering that 90% of HGPS patients 
die because of atherosclerosis associated myocardial infarct or stroke.  Patients exhibited various 
musculoskeletal physical abnormalities including decreased spinal flexation (11/11), stooped shoulders 
(11/11), calcaneovalgus (9/11), subluxed finger joints (7/11), genu valgum (4/11), kyphosis (3/11), and 
calcaneo varus (1/11), resulting in functional impairments (Merideth et al., 2008).  Muscle strength and 
muscle volume to body mass is normal 
(Merideth et al., 2008).  Blood tests revealed 
elevated platelet counts (14/15), prolonged 
prothrombin time (8/11), elevated levels of 
serum phosphorus (8/15), serum 
triglycerides (5/14), total cholesterol 
(elevated low-density lipoprotein cholesterol 
(4/14) and reduced high-density lipoprotein 
cholesterol (10/14)) (Merideth et al., 2008).   
 
 
 Figure 1.  A-type and B-type lamins.   
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1.3. LMNA AND NUCLEAR LAMINS 
 
 
The HGPS mutation occurs in the LMNA gene which encodes the A-type nuclear lamins:  lamin A, lamin 
C, lamin AΔ10, and lamin C2.  Lamin AΔ10 and the male germ cell specific C2 are minor isoforms that 
have been minimally investigated (Figure 1).  The A-type lamins, together with the B-type lamins, lamin 
B1 encoded by the LMNB1 gene and lamins B2 and B3 encoded by the LMNB2 gene (Figure 1), form the 
nuclear lamina, a scaffold-like structure that lines the inside of and interacts with the inner nuclear 
membrane.  There is evidence that nuclear lamins 
are also present throughout the nucleoplasm, 
contributing to a nuclear matrix (Hozak et al., 
1995).  Nuclear lamins are type-V intermediate 
filament proteins that are categorized into the A- 
and B-subtypes based on sequence homologies.   
The nuclear lamins consist of a globular N-
terminal head domain, followed by a central α
helical coiled-coil rod domain, and a C-termin
domain (Figure 1).  Lamins A, B1, and B2, the 
primary nuclear lamin isoforms contain a CAAX 
motif at the C terminus that is post-translationally 
modified.  Lamin proteins form parallel coiled-coil 
homodimers, which then align head to tail to form 
protofilaments, that interact laterally to form 
higher-order filaments.  A recent report suggests 
that lamins do not form heterodimers (Delbarre et 
al., 2006).  Little is known about how the lamin 
-
al tail 
Figure 2.  Pre-lamin A Processing.  The image shows 
exon 11 (E11) and exon 12 (E12) in blue not drawn to 
scale.  Exon 12 ends in the CaaX motif, CSIM.  FTase 
= farnesyl transferase. 
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filaments associate in vivo to form the nuclear lamina, or their nucleoplasmic organization.   
 
Lamin A is synthesized as prelamin A, a precursor molecule consisting of exons 1-12 that is subsequently 
modified in four steps to yield mature lamin A (Figure 2).  The first step is farnesylation of the cysteine 
residue within the CaaX motif by protein farnesyltransferase (Sinensky et al., 1994).  Subsequently, the 
protein undergoes endonuclease cleavage by RCE1 which removes the last three amino acids (Bergo et 
al., 2002; Corrigan et al., 2005).  The exposed farnesylcysteine is then methylated by isoprenylcysteine 
carboxyl methyltransferase (Bergo et al., 2002).  The last processing step is internal proteolytic cleavage 
by ZMPSTE24, removing the last 15 carboxy-terminal amino acids, including the farnesylcysteine methyl 
ester to generate mature lamin A (Bergo et al., 2002; Corrigan et al., 2005; Sinensky et al., 1994).  The 
initial farnesylation step is necessary for the subsequent proteolytic modifications (Bergo et al., 2002).  
Evidence suggests that farnesylation targets farnesyl-prelamin A to the inner nuclear membrane and that 
the final ZMPSTE24 endoproteolytic step releases mature lamin A, allowing it to properly incorporate into 
the nuclear lamina.   
 
Whereas lamins B1 and B2 are present ubiquitously, lamins A and C are expressed primarily in 
differentiated cells.  Mouse studies have shown that during development lamin A is fist detected in the 
trophectoderm around day 9 and in the embryo proper around day 12 (Prather et al., 1991; Prather et al., 
1989; Rober et al., 1989; Schatten et al., 1985; Stewart and Burke, 1987).  In most tissues it is not 
detected until late development and in some LMNA expression is only observed post-natally.  Lamins A 
and C are absent or expressed at low levels in undifferentiated cells such as embryonic carcinoma (EC) 
(Stewart and Burke, 1987).  Further, studies have produced mixed results regarding the expression of 
lamin A in undifferentiated adult cells and certain adult stem cell populations (Broers et al., 1997; Lourim 
and Lin, 1989a; Rober et al., 1989; Scaffidi and Misteli, 2008).  Further, lamin A is not expressed in 
mouse (mES) or human (hES) embryonic stem cells, but is upregulated upon hES cell differentiation 
((Presented here; (Constantinescu et al., 2006)).  These expression patterns indicate a correlation 
between differentiation and lamin A expression, and some have proposed that lamin A may be involved in 
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maintaining the differentiated state, perhaps by stabilizing chromatin patterns and hence gene 
expression.  However, a specific study in which chicken lamin A was stably expressed in undifferentiated 
human embryonic carcinoma cells resulted in no detectable affect on differentiation (Peter and Nigg, 
1991).  The presence of lamin A neither induced differentiation, nor maintained the pluripotent state.  
Ideally, this experiment should be performed with the expression of human lamin A in non-tumor derived 
undifferentiated cells such as human embryonic stem cells.  My own attempts to stably express a GFP-
Lamin A construct in hES cells failed despite, despite consistent success in stably expressing GFP alone 
in hES cells (non-published results) and the GFP-Lamin A construct in differentiated cells (Figure 11).  
This raises the possibility that the presence of lamin A in undifferentiated ES cells is toxic resulting in cell 
death.  More extensive studies are needed to fully identify the role of lamin A/C with respect to 
differentiation.   
 
 
 
1.4. A-TYPE LAMIN FUNCTION 
 
 
A-type lamins provide nuclear structural support and have been shown to be important for chromatin 
organization and nuclear positioning as well as DNA replication (Kennedy et al., 2000; Shumaker et al., 
1998; Spann et al., 1997) and transcription (Spann et al., 2002),  processes which are believed to be 
dependent on proper nuclear structural and chromatin organization.  LMNA -/- mice develop normally, but 
exhibit growth retardation and muscular dystrophy after birth, resulting in early death (Sullivan et al., 
1999). The nuclei in embryonic fibroblasts from LMNA-/- mice display abnormal nuclear shapes and 
mislocalization of B-type lamins and emerin, a lamin-binding inner nuclear membrane protein (Clements 
et al., 2000).  Interestingly, expression of lamin C, in the absence of lamin A, appears to be sufficient to 
maintain relatively normal cellular characteristics (Fong et al., 2006b). 
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The nuclear lamins appear to be important for nuclear assembly post-mitosis and there appear to be 
differences in the functions of A-type and B-type lamins.  During the transition from late prophase to 
metaphase the nuclear envelope breaks down in preparation for cell division.  Disassembly of the nuclear 
lamina is activated through phosphorylayion of lamin subunits by p34sdc2, resulting in the formation of 
lamin monomers, dimers, and tetramers (Dessev et al., 1991; Gerace and Blobel, 1980; Newport and 
Spann, 1987; Ottaviano and Gerace, 1985; Peter et al., 1990).    Disassembly of the different lamin 
isoforms appears to occur at different rates; A-type lamins are released during early prophase, whereas 
B-type lamins are remain at the nuclear periphery until prometaphase (Georgatos et al., 1997).  The 
manner of nuclear lamina assembly following mitosis and the role of in nuclear assembly is more 
controversial.  It is believed that nuclear lamin dephosphorylation, perhaps by the PP1 family of 
serine/threonie phosphotases (Steen et al., 2000; Thompson et al., 1997), is necessary for reassembly of 
the nuclear envelope after mitosis.  There is evidence to suggest that lamins interact with NE components 
and have a functional role in envelope formation early during assembly (Burke and Gerace, 1986; 
Dabauvalle et al., 1991; Lourim and Krohne, 1993).  Alternatively there is also evidence indicating that 
lamins have no functional role in nuclear assembly and are imported into nuclear vesicles that have 
formed around chromatin and have functional nuclear pores (Meier et al., 1991; Newport et al., 1990).  
Both scenarios can be reconciled by a model in which only a small fraction of the total amount of lamins 
takes part in envelope formation and the remaining lamins are imported into the nucleus when nuclear 
pore complexes become functional.  Further research is necessary to fully elucidate the order of events of 
lamina reassembly and any functional role lamins may have in nuclear envelope assembly. 
  
Multiple lines of evidence suggest that A-type lamins are important for local chromatin organization and 
positioning throughout the nucleus.  The first line of evidence is the multiple direct and indirect 
interactions between A-type lamins and chromatin.  A-type lamins have been shown to bind mitotic 
chromosomes (Burke, 1990; Glass et al., 1993; Glass and Gerace, 1990) and polynucleosomal particles 
in vitro (Yuan et al., 1991).  Specifically, A-type lamins have been shown to interact with chromatin by 
binding histones (Glass et al., 1993; Hoger et al., 1991; Schmidt and Krohne, 1995; Taniura et al., 1995; 
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Yuan et al., 1991) and DNA directly (Shoeman and 
Traub, 1990; Stierle et al., 2003).  A-type lamins 
also interact with chromatin indirectly through 
lamin-binding proteins, including LAP2α (Dechat et 
al., 2000) and barrier-to-autointegration (BAF) 
(Holaska et al., 2003).  The second line of evidenc
comes from cells with various LMNA mutations that 
exhibit irregularities in chromatin organization.  
LMNA-/- fibroblasts have regions exhibiting a 
dissociation of heterochromatin from the nuc
envelope (Nikolova et al., 2004; Sullivan et al., 
1999).  Cells from patients with AD-EDMD 
(Sabatelli et al., 2001), FPLD (Capanni et al., 
2003), MAD (Filesi et al., 2005),  and HGPS 
(Columbaro et al., 2005; Goldman et al., 2004) 
exhibit a similar dissociation or loss of 
heterochromatin.  Cells from patients with MAD 
also exhibit changes in H3K9me3 patterns, a 
marker of constitutive heterochromatin (Filesi et al
2005).  A third line of evidence shows that LMNA 
mutations result in chromatin repositioning.  LMNA-
/- cells exhibit altered localization of a gene
on human chromosome 4 associated with 
acioscapulohumeral muscular dystrophy (FS
(Masny et al., 2004).  Further, chromosome 
territories, 13 and 18, are repositioned form the 
e 
lear 
., 
tic locus 
HD) 
Figure 3.  HGPS mutations and abnormal post-
translational processing. A) The G608G and G608S 
HGPS mutations within exon 11 increase the 
sequence similarity between the wildtpye sequence 
and the indicated donor splice sequence.  The 
mutations can result in aberrant splicing within exon 
11, removing 50 amino acids including the ZMPSTE 
cleavage site.  B) Processing of the mutated form of 
lamin A.  Interference with ZMPSTE cleavage leaves 
“Progerin” as the final processing product.   
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nuclear periphery to the interior of the nucleus in some diseases caused by LMNA mutations (Meaburn et 
l., 2007).   
 
 
1.5. HGPS MUTATION 
e 150 
003) (Figure 
ly 
A 
.  
PS, which exhibit a similar clinical phenotype to classical HGPS 
soka et al., 2004a).  However, the mechanism of action is probably different since these mutations do 
ot result in the production of Progerin. 
 
a
 
 
 
The most prevalent mutation associated with HGPS is a single nucleotide substitution, 1824C>T in codon 
608 within exon 11 of the LMNA gene (Figure 3A).  This mutation along with another less prevalent 
mutation, 1822G>A results in partial activation of a cryptic splice site (Figure 3A), and removal of th
carboxy-terminal nucleotides in exon 11 (De Sandre-Giovannoli et al., 2003; Eriksson et al., 2
3A).  This aberrant splicing event maintains the CAAX motif, but removes the internal ZMPSTE24 
cleavage site that is needed for lamin A maturation, resulting in permanent farnesylation and 
carboxymethylation (Figure 3B).  This protein product, termed Progerin/LAdelta50 remains preferential
localized to the nuclear lamina, since it cannot undergo the final ZMPSTE24-mediated endoproteolytic 
cleavage step (Goldman et al., 2004).  It has been estimated that only 10-50% of the mRNA from the 
mutated allele is spliced incorrectly, and since the second LMNA allele is normal, the majority on mRN
results in the production of wildtype lamin A, albeit at lower levels (De Sandre-Giovannoli et al., 2003)
Multiple other mutations in LMNA, collectively termed laminopathies, appear to produce an variety of 
diseases (Rankin and Ellard, 2006).  Some of these mutations are responsible for a growing class of 
laminopathies, referred to as Atypical HG
(C
n
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1.6. HGPS CELLULAR AND MOLECULAR PHENOTYPES 
3; 
l stress 
 
d 
it 
ive 
i 
 
K27 
2 
sible 
 
 
 
 
Various pathological cellular and molecular phenotypes have been described for HGPS cells.  First, 
HGPS cells exhibit multiple nuclear structural irregularities including an abnormal nuclear shape, 
characterized by lobes and invaginations in the nuclear envelope (De Sandre-Giovannoli et al., 200
Eriksson et al., 2003; Goldman et al., 2004), thickening of the lamina (Goldman et al., 2004), and altered 
spatial distribution of NPCs (Goldman et al., 2004).  These abnormal structural characteristics are 
accompanied by functional changes, including loss of structural nuclear integrity under mechanica
(Lammerding et al., 2004) as well as mitotic defects, including abnormal chromosome segregation, delays
in cytokinesis and nuclear reassembly, and binucleation (Cao et al., 2007; Dechat et al., 2007).   
HGPS cells also exhibit altered chromatin organization in interphase nuclei, similar to changes observe
in other diseases caused by LMNA mutations as previously discussed.  Particularly, HGPS cells exhib
loss of peripheral heterochromatin (Columbaro et al., 2005; Goldman et al., 2004) that may be due to 
epigenetic changes, including upregulation of H3K9me3 and H4K20me3, which define constitutat
heterochromatin and downregulation of H3K27me3 which defines facultative heterochromatin (Columbaro 
et al., 2005; Goldman et al., 2004; Scaffidi and Misteli, 2005).  In addition to epigenetic changes, 
HP1alpha, which is usually associated with H3K9me3 is down-regulated and partially dissociated (Scaffid
and Misteli, 2005; Shumaker et al., 2006).  The decrease in H3K27me3 may due to a reduction in the
expression of enhancer of zeste homolog (EZH2), the histone methyltransferase responsible for H3
trimethylation (Shumaker et al., 2006).  The retinoblastoma gene product (pRb), which binds A-type 
lamins in vitro (Ozaki et al., 1994) and whose hyperphosphorylated form is reduced in HGPS cells 
(Dechat et al., 2007) may also be responsible for epigenetic changes.  pRB regulates expression of EZH
(Bracken et al., 2003) and associates with and regulates the HMTs, SUV39H1 and Suv4-20h, respon
for H3K9 and H4k20 trimethylation, respectively (Gonzalo et al., 2005; Isaac et al., 2006; Nielsen et al.,
2001).  Changes in constitutative and facultative heterochromatin, which are associated with gene 
expression inhibition, are expected to result in gene expression changes, especially gene activation.  
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There is some evidence to suggest that these epigenetic chromatin alterations do bring about gene 
expression changes.  The decrease in H3K9Me3 in pericentric regions of HGPS cells coincides with 
upregulation of pericentric chromosome 9 sat III transcripts (Shumaker et al., 2006).  Further, loss
H3K27me3 on t
 of 
he inactive X chromosome (Xi) due to expression of Progerin leads to decondensation of 
i (Shumaker et al., 2006), although it remains unknown if this is accompanied by transcriptional 
these 
 
 within appropriate ranges (Wallis et al., 2004).  
his variability may be due to occasional loss of the mutated allele and subsequent selection of these 
ge.  
X
upregulation.   
 
Telomere length has been shown to correlate inversely with age and senescence and directly with 
replicative capacity in vitro (Reviewed in (Aubert and Lansdorp, 2008)).  It has been reported that primary 
cells derived from individuals diagnosed with HGPS have shorter telomeres than age matched controls 
(Allsopp et al., 1992).  However, this study was performed prior to identification of the HGPS mutation so 
it is not known for certain whether the donors were afflicted with classical HGPS (608 mutation). Since it 
has been shown that diagnosis of classical HGPS based on clinical features is not always accurate, 
results have to be regarded with skepticism.  Furthermore it has been reported that primary HGPS cells
can be immortalized with telomerase (Ouellette et al., 2000; Wallis et al., 2004), but that clonogenic 
variance exists (Wallis et al., 2004).  It was reported that one third of HGPS clones did not immortalize 
even though telomerase levels and telomeres lengths were
T
cells during proliferation, but this has not been confirmed. 
 
Interestingly, multiple lines of evidence indicate that HGPS cells exhibit elevated levels of DNA dama
First, HGPS cells demonstrate limited proliferative capacity in culture, early onset of senescence, and 
increased apoptosis (Bridger and Kill, 2004), all of which can be caused by DNA damage.  Second, 
HGPS cells exhibit elevated activity of DNA damage response pathways (Liu et al., 2006).  Lastly, the 
most direct evidence of elevated DNA damage comes from a study which showed that HGPS and 
ZMPSTE24-/- cells have a DSB repair defect that may be specific to homologous recombination (HR) 
repair (Liu et al., 2005).  Furthermore, both HGPS and ZMPSTE24-/- cells exhibited less localization of 
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the DSB repair factors Rad50 and Rad51 and prolonged association of 53BP1, a DNA damage signal
molecule.   Altogether, these studies indicat
ing 
e that Lamin A is important for proper DNA damage repair 
nd that DSB repair in compromised in HGPS cells, but the extent and the manner of the DSB repair 
 
air phenotype 
s HGPS cells (Liu et al., 2005) suggests that the DNA damage repair defect is due to the over-
PS 
, 
 
.  
 Toth 
f 
a
impairment has not been fully elucidated.   
 
It has been demonstrated that the nuclear morphological changes and some of the altered chromatin 
characteristics are not caused by lamin A haploinsufficiency, but by the presence of Progerin in a 
dominant gain-of-function fashion, possibly through its accumulation at the INM (Goldman et al., 2004; 
Scaffidi and Misteli, 2005), where it appears to alter nuclear lamina structure (Dahl et al., 2006). 
Furthermore, the observation that ZMPSTE24-/- MEFs results in a similar DNA damage rep
a
accumulation of Progerin at the INM, perhaps also in a dominant gain-of-function manner. 
 
Accordingly, studies aimed at reducing the level of Progerin have shown improvement in many HG
cellular phenotypes.  One successful approach has been to use progerin specific aintisense morpholinos
which target the aberrant splice site, inhibiting splicing (Scaffidi and Misteli, 2005).  Although, this
approach is biologically and mechanistically ideal since it specifically inhibits the production of Progerin 
without affecting lamin A production, clinical application is thwarted by the inability to safely and 
accurately deliver desired quantities of morpholinos to all the tissues affected by HGPS in vivo.  Another 
successful approach has been to treat HGPS cells with farnesyl transferase inhibitors (FTIs), which inhibit 
farnesyl transferase and thus post-translational modification of Progerin.  This approach is based on the 
hypothesis that HGPS pathology is caused by the modified form of Progerin which aggregates at the INM
FTI treatment can improve some of the nuclear abnormalities in vitro as well as the overall health in 
LMNA HG/+ mice (Capell et al., 2005; Fong et al., 2006a; Glynn and Glover, 2005; Liu et al., 2006;
et al., 2005; Yang et al., 2006; Yang et al., 2008), but one report suggests that FTIs do not reduce the 
elevated levels of DNA damage response pathways in HGPS cells (Liu et al., 2006).   FTIs do not 
specifically inhibit modification of Progerin, resulting in inhibition of lamin A as well as the modification o
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other unrelated proteins that are farnesylated.  Although this makes FTI treatment less than ideal, FTIs do 
not appear to have major adverse effects as shown by clinical studies aimed at treating cancer.  Their 
pparent safety and ease of administration, as well as the lack of any other therapeutic treatment, has led 
 
  mice 
 
ote 
 
o 
ge.  
re 
type in this model may be due to the low levels of human progerin relative to wildtype mouse 
lamin A or a less potent effec igh level of sequence 
omology 
a
to a current phase II clinical trial to treat HGPS patients (ClinicalTrials.gov identifier: NCT00425607). 
 
Two groups have created mouse models to study HGPS.  Yang et al. have created targeted LmnaHG/+  
and LmnaHG/HG mouse models, using a Lmna targeting vector missing the last 150 nucleotides from exon
11, so that that the construct produces a mouse version of progerin, exclusively (Yang et al., 2005; Yang 
et al., 2006).  The authors show that a higher percentage of embryonic fibroblasts from LmnaHG/+
display an abnormal nuclear morphology.  The LmnaHG/+  mice developed normally, but began exhibiting
reduced weight gain by 6-8 weeks. The mice also displayed lypodystrophy and various skeletal 
abnormalities, similar to HGPS patients.  Survival rate for LmnaHG/+  was severely reduced.  50% of the 
LmnaHG/+  mice died or were euthenized due to severity of phenotype by 27 weeks of age.   LmnaHG/HG 
exhibited similar phenotypes, but more severe, and died by 5-6 weeks after birth.  It is important to n
that because the targeting construct produces progerin exclusively, LmnaHG/+ mice likely express a higher
level of progerin than is present in HGPS patients.  Varga et al. have also created an HGPS mouse 
model by introducing a bacterial artificial chromosome expressing the mutated (G608G) human genomic 
sequence (Varga et al., 2006).  Thus the transgenic mice have two wildtype mouse Lmna alleles, and a 
mutated (G608G) human LMNA allele that was reported to express human lamin A, C and progerin.  N
external characteristics associated with HGPS or lifespan differences were detected by 20 months of a
The transgenic mice did show a progressive degeneration of vascular tissue, characterized by loss of 
smooth muscle cells and changes in extracellular matrix composition.  Similar vascular changes have 
been described in HGPS patients, which display a rapid onset of atherosclerosis.  The lack of a seve
HGPS pheno
t of human progerin in mouse cells despite the h
h
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1.7. DNA DOUBLE-STRAND BREAK REPAIR 
 
 
Cellular DNA is under constant attack from endogenous and exogenous agents resulting in various type 
of DNA damage, including single- (SSBs) and double-strand breaks (DSBs), DNA-protein crosslinks, and
various base damage.  DNA DSBs are the most dangerous form of DNA damage since such lesions can 
result in loss or rearrangement of genetic information as well as cell death.   DSBs are produced natu
as part of the mechanisms for various biological processes such as V(D)J recombination (Franco et a
2006), class-switch recombination (Chaudhuri et al., 2007), and meiosis (Keeney and Neale, 2006).
can also occur during DNA replication when replication forks encounter blocking lesions that can be 
produced by reactive oxygen species (ROS), chemical agents, and UV radiation (Bosco et al., 2004; 
Limoli et al., 2002).  Further, they can be produced by ionizing radiation, either directly or indirectly 
through production of reactive oxygen species (ROS).   Cells have developed DNA damage resp
 
rally 
l., 
  They 
onse 
athways that detect DSBs, transiently arrest the cell cycle, and activate repair mechanisms (Reviewed in 
ut if 
ed 
ng 
 
ation form the donor locus 
p
(Kobayashi et al., 2008; Shrivastav et al., 2008)).  If repair is successful cells re-enter the cell cycle, b
DSBs are irreparable cells can undergoe apoptosis to prohibit inheritance of genomic lesions.   
 
Eukaryotic cells have developed two primary mechanisms for repair of DSBs: non-homologous end 
joining (NHEJ) and homologous recombination (HR) (Reviewed in (Shrivastav et al., 2008)).  It is believ
that DSBs produced during replication through replication fork collapse are primarily repaired via HR, 
whereas other DSBs can be repaired by either mechanism.   NHEJ exhibits variable accuracy dependi
on the type of DSB being repaired, but generally results in small deletions or insertion at the DSB, and
thus in alteration of the local nucleotide sequence.  HR utilizes a homologous region (sister chromatid, 
homologous chromosome, or repeated regions on the same or different chromosome) to prime repair 
synthesis.  The accuracy of repair depends on the homology of the repair template which is often not 
100% accurate if the sister chromatid is not used, resulting in transfer of inform
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to the recipient locus.  Further evidence form yeast suggests that the repair polymerase used in HR is n
as accurate as those involved in DNA replication, resulting in a higher rate of point mutations (Strathern et 
al., 1995).  Nonetheless, HR is considered to be more accurate than NHEJ.   
 
It is thought that both NHEJ and HR compete for repair of DSBs.  This was suggested by experiments
showing that both mechanisms actively repair plasmid DNA transfected into mammalian cells.  It ha
been shown that when NHEJ is defective HR capacity increases, consistent with a competitive model 
(Reviewed in (Shrivastav et al., 2008)).  There are differences in which repair pathway is preferentially 
used from cell type to cell type and throughout the cell cycle that appear to be due to both active and 
passive mechanisms (Reviewed in (Shrivastav et al., 2008)).  Active mechanisms include differing 
expression levels or functionality of proteins involved in or in control of either type of repair.  For examp
RAD51 and RAD52, repair factors involved in HR are overexpressed during S phase (Chen et a
in which HR capacity has been shown to be increased.  Further, p53 has been shown to be a suppress
of HR (Reviewed in (Gatz and Wiesmuller, 2006)).  Accordingly, mouse ES cells which have decrea
p53 function (Chen et al., 1997) have greater HR capacity.  Passive mechanisms include the different 
accessibility of a homologous template throughout the cell cycle.  It has been show
ot 
 
s also 
le, 
l., 1997) 
or 
sed 
n that sister 
hromatids are the preferred template in mammalian cells (Dronkert et al., 2000; Kadyk and Hartwell, c
1992), probably due to the close physical proximity until separation in anaphase.  Accordingly, HR 
appears to be the predominant repair pathway during S and G2 phases of the cell cycle although NHEJ 
repair is still active during these phases (Reviewed in (Shrivastav et al., 2008)).   
 
The repair machinery involved in HR repair includes various proteins.  One such component is the MRN 
complex (MRE11, RAD 50, and NBS1).  The MRN complex is essential for DSB repair as shown by the 
observation that null mutations in any of the three component proteins results in embryonic lethality 
mice (Luo et al., 1999; Xiao and Weaver, 1997; Zhu et al., 2001).  Furthermore, Nijmegen breakage
syndrome (Carney et al., 1998; Varon et al., 1998) and ataxia telangiectasia-like disorder (Stewart et al., 
1999), which are characterized by radiation hypersensitivity, are caused by mutations in the NBS1 and 
in 
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MRE11 genes, respectively.  In humans, MRN acts both as a damage sensor and is believed to be 
involved in the early steps of HR repair (Reviewed in (Williams et al., 2007)).  The MRN complex is 
believed to function as both a long range tethering scaffold to hold large chromosomal domains in place
as well as short range DNA synaptic structures that hold the two broken chromosome ends at a DSB 
close proximity (Reviewed in (Williams et al., 2007)).  Reports indicate that other factors are
at least in the long range tethering scaffolds (Sjogren and Nasmyth, 2001; Strom et al., 2007).  The MRN 
complex is also important in activation of DNA damage response pathways through activation of ATM.
The current understanding is that NBS1 binds ATM physically recruiting it to DSBs and also helps to 
activate ATM kinase activity (Lee and Paull, 2005; You et al., 2005).  Once activated, ATM 
phosphorylates numerous targets that regulate cell cycle checkpoints and DNA damage repair, including
 
in 
 also involved 
  
 
2AX, Chk2, and p53 (reviewed in (Kurz and Lees-Miller, 2004).  Lastly, the MRN complex has been 
plicated in chromatin remodeling near DSBs.  MRE11 is important for histone removal in the area 
urrounding DSBs (Reviewed in (Williams et al., 2007)).  Similalry, MRN has been linked with the 
cruitment and/or activity of various chromatin remodeling proteins (reviewed in (Williams et al., 2007). 
 
 
 
 
H
im
s
re
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CHAPTER II: LAMIN A/C EXPRESSION IS A MARKER OF MOUSE AND HUMAN EMBRYONIC STEM 
CELL DIFFERENTIATION 
 
 
 
2.1 RATIONALE 
 
 
The rational for examining the expression of nuclear lamins in mouse and human ESCs was two fold.  
One purpose of the experiments was to determine whether Progerin is present during early human 
development.  Since Progerin acts in a dominant gain-of-function manner it can only exert its adverse 
effects if the LMNA gene is expressed.  Although HGPS has traditionally been described as an 
“accelerated aging” disorder because it exhibits many characteristics associated with old age 
prematurely, it also manifests multiple pathologies that point to developmental defects.  For example, a 
recent study categorizing HGPS clinical phenotypes identified the following developmental abnormalities: 
hypodontia (7/11), ankyloglossia (7/14), circumoral cyanosis (13/15), ogival palate (8/15), delayed tooth 
eruption (12/15).   Interestingly, it is possible that some of the characteristics associated with aging may 
be causally rooted in more fundamental developmental defects.  Irrespective of such a putative 
relationship, investigating developmental defects in HGPS is important for fully understanding the 
pathophysiology and progression of the disease.  Examination of LMNA expression in ESCs, which are 
representative of pluripotent inner mass cells, allows us to determine whether Progerin is present and 
whether HGPS pathology begins during early human embryonic development.   
 
The second rationale was to further examine whether there is a correlation between LMNA expression 
and an undifferentiated state in human cells.  It is commonly accepted that most, if not all, human tissues 
maintain cellular homeostasis through continual regeneration from tissue-specific multipotent adult stem 
cell pools.  It has even been hypothesized that functional loss of adult tissue-specific stem cell pools 
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contributes to normal aging (Reviewed in (Rossi et al., 2008; Sharpless and DePinho, 2007)).  If LMNA is 
expressed and Progerin is present in undifferentiated adult stem cells, the cells may experience 
increased rates of apoptosis and early onset of senescence, which may contribute to the accelerated 
aging phenotype observed in HGPS.   
 
 
 
2.2 ABSTRACT 
 
 
Nuclear lamins comprise the nuclear lamina, a scaffold-like structure that lines the inner nuclear 
membrane.  B-type lamins are present in almost all cell types, but A-type lamins are expressed 
predominantly in differentiated cells, suggesting a role in maintenance of the differentiated state.   
Previous studies have shown that lamin A/C is not expressed during mouse development before day 9, 
nor in undifferentiated mouse embryonic carcinoma (EC) cells.  To further investigate the role of lamins in 
cell phenotype maintenance and differentiation, we examined lamin expression in undifferentiated mouse 
and human embryonic stem (ES) cells.   Wide-field and confocal immunofluorescence microscopy and 
semi-quantitative RT-PCR analysis revealed that undifferentiated mouse and human ES cells express 
lamins B1 and B2, but not lamin A/C.  Mouse ES cells display high levels of lamins B1 and B2 localized 
both at the nuclear periphery and throughout the nucleoplasm, but in human ES cells, B1 and B2 
expression is reduced and localized primarily at the nuclear periphery.  Lamin A/C expression is activated 
during human ES cell differentiation, prior to down-regulation of the pluripotency marker, Oct-3/4, but not 
before the down-regulation of the pluripotency markers Tra-1-60, Tra-1-81, and SSEA-4.  Our results 
identify the absence of A-type lamin expression as a novel marker for undifferentiated ES cells and 
further support a role for nuclear lamins in cell maintenance and differentiation. 
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2.3 INTRODUCTION 
 
 
Nuclear lamins are intermediate filament proteins that were originally identified as components of the 
nuclear lamina (Aebi et al., 1986; McKeon et al., 1986), a 10-50 nm thick meshwork of proteins that 
underlies the inner nuclear membrane (Fawcett, 1966).  It had traditionally been thought that the nuclear 
lamina functions primarily to provide structural support and organization to the nuclear envelope (Csoka 
et al., 2004a; Lammerding et al., 2004; Lenz-Bohme et al., 1997; Newport et al., 1990; Smythe et al., 
2000; Sullivan et al., 1999; Vigouroux et al., 2001), but recent reports have documented that lamins exist 
throughout the nucleoplasm, suggesting structural contributions to a nuclear matrix (Bridger et al., 1993; 
Goldman et al., 1992; Hozak et al., 1995) and roles in DNA replication (Moir et al., 2000), transcription 
(Spann et al., 2002), and RNA processing (Jagatheesan et al., 1999; Kumaran et al., 2002; Muralikrishna 
et al., 2001).   Mutations in lamins have also been assigned a causative role in the group of diseases 
collectively called laminopathies (Reviewed in (Burke and Stewart, 2002; Mounkes et al., 2003)). 
 
In mammals, seven lamin proteins, which are the products of three genes, have been identified and can 
be divided into two subtypes.  B-type lamins include B1, encoded by the LMNB1 gene, and B2 and B3, 
splice variants of the LMNB2 gene (Biamonti et al., 1992; Furukawa and Hotta, 1993; Pollard et al., 
1990).  A-type lamins, A, AΔ10, C, and C2 are all splice variants of the LMNA gene (Fisher et al., 1986; 
Furukawa et al., 1994; Machiels et al., 1996).  Lamins B3 and C2 are expressed only in male germ cells 
(Furukawa and Hotta, 1993; Furukawa et al., 1994).  The remaining B-type lamins are present 
ubiquitously in embryonic and adult cell types.  At the cellular level, lamins B1 and B2 are essential for 
cell growth and survival (Harborth et al., 2001).  lmnB1 knock-out mice exhibit abnormal lung and bone 
development and die at birth (Vergnes et al., 2004).  Contrastingly, A-type lamins are primarily found in 
differentiated cells.  During mouse embryonic development, expression of A-type lamins is first detected 
on day 9 in extra-embryonic tissues and on day 12 in the embryo itself (Prather et al., 1991; Prather et al., 
1989; Rober et al., 1989; Schatten et al., 1985; Stewart and Burke, 1987).  Embryonic carcinoma cells 
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generally express little or no A-type lamins (Peter and Nigg, 1991; Stewart and Burke, 1987).  Lastly, 
certain adult cell types that are not fully differentiated also express little or no A-type lamins (Lourim and 
Lin, 1989b; Rober et al., 1989).  Consistent with these findings, lamin A/C is not essential for cell growth 
and survival (Harborth et al., 2001).  Although lmna  knock-out mice exhibit normal development at birth, 
they soon develop retarded postnatal growth and a muscular dystrophy phenotype that results in death by 
eight weeks of age (Sullivan et al., 1999).  The detection of A-type lamins primarily in differentiated cells 
suggests that they might function to limit developmental plasticity by maintaining a cell’s differentiated 
phenotype (Rober et al., 1989). 
 
ES cells are obtained from the inner cell mass of blastocyst stage embryos and exhibit unlimited 
proliferative capacity and pluripotency (Magnuson et al., 1982; Thomson et al., 1998).  The ability of ES 
cells to differentiate into all cell types of the embryo suggests that they are ideal candidates for 
therapeutic use.  However, the specific differentiation of ES cells toward desired lineages remains 
ineffective, resulting in mixtures of differentiated cells.  Further, due to the proliferative capacity of ES 
cells and their tendency to form teratomas when transplanted into animals (Gropp et al., 2003; Reubinoff 
et al., 2000), it is important to ensure that differentiated cells do not revert back to an ES cell phenotype 
after transplantation.  Such reversion has been reported for mouse muscle-derived stem cells after 
differentiation into hematopoietic lineages (Cao et al., 2003), and for drosophila spermatogonial stem 
cells that have differentiated into spermatogonia (Brawley and Matunis, 2004).  Thus, prior to clinical 
applications, it is necessary to understand the mechanisms controlling ES cell differentiation and the 
maintenance of the differentiated state.  Given the possible role of nuclear lamins in cell maintenance and 
differentiation, we decided to characterize their expression in mouse (mES) and human (hES) ES cells.  
We report that 129/SVEV mES cells and HSF-6 hES cells express lamins B1 and B2, but not lamin A/C, 
and that as HSF-6 hES cells begin to differentiate into neuronal lineages and cardiomyocytes, lamin A/C 
expression is activated.  Our results demonstrate that lamin A/C expression is a reliable marker of ES cell 
differentiation. 
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2.4 RESULTS 
 
 
2.4.1 Undifferentiated mES and hES cells do not express A-type lamins. 
 
Semi-quantitative RT-PCR analysis with human-specific primers was used to examine lamin A/C 
expression levels in HSF-6 hES cells.  The centers of several HSF-6 hES cell colonies were scraped 5 
days after passage to isolate undifferentiated cells and exclude peripheral cells that might be  
differentiating (Figure 4A, B).  Whole colonies were also scraped 10 days after passage to examine 
whether lamin A/C expression is activated in some peripheral cells.  Using this method, we show that 
HSF-6 hES cells, obtained by center colony scraping that are undifferentiated by morphological 
appearance (Figure 4A), express Oct-4, but little or no detectable lamin A/C (Figure 4C, lane 2).  In 
contrast, differentiated WI-38 control cells express lamin A/C (Figure 4C, lane 1).  However, lamin A/C 
was detected in whole colony scrapings (Figure 4C, lane 3), suggesting that lamin A/C expression is 
activated in some peripheral ES cells that are, presumably, differentiating.  Immunocytochemistry 
experiments corroborated the RT-PCR results, demonstrating a lack of lamin A/C in HSF-6 hES cells and 
129SV/EV mES (Figure 5).  The pluripotency markers, Oct-
4, (Pesce et al., 1998; Reubinoff et al., 2000; Thomson et 
al., 1998), TRA-1-60 (Andrews et al., 1984; Thomson et al., 
1998), TRA-1-81 
Figure 4.  Detection of lamin mRNA in hES cells.  HSF-6 
hES cells were cultured for 5 days after passage and the 
centers of colonies were scraped to obtain a pure population 
of undifferentiated HSF-6 hES cells for RNA isolation (A, B).  
Whole HSF-6 hES cell colonies cultured for 10 days after 
passage, consisting of undifferentiated and differentiated cells 
were also scraped for RNA isolation (not shown).  (C) RT-PCR 
of WI-38 fibroblasts (lane 1), HSF-6 center colony scrapings 
(CCS) (lane 2), and HSF-6 whole colony scrapings (WCS) 
(lane 3). 
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 (Andrews et al., 1984; Thomson et al., 1998), and SSEA-4 (Kannagi et al., 1983; Thomson et al., 1998) 
 
ip
ot 
t 
(MEF) feeder cells adjacent to the mES cells 
were used to identify undifferentiated cells along with morphological observations  
(undifferentiated ES cells are relatively small (8-10 micrometers diameter) with a high nucleus/cytoplasm
ratio).  Undifferentiated HSF-6 hES cells, that are positive for Oct-4 (Figure 5B), TRA-1-60 (Figure 5E), 
TRA-1-81 (Figure 5H), and SSEA-4 (Figure 5K), lack lamin A/C (Figure 5C, F, I, and L), but adjacent CF-
otency markers are lamin A/C positive.  Similar 
results were obtained with the H1 hES cell line 
(not shown).  Further, 129/SVEV mES cells, as 
identified by Oct-4 labeling (Figure 5N), do n
express lamin A/C (Figure 5O).  In contrast, 
differentiated SNL mouse embryonic fibroblas
1 MEF feeder cells that are negative for each of the plur
Figure 5.  hES  and mES cells do not contain 
lamin A/C.  HSF-6 hES cells were fixed with 100% 
methanol (A-C) or 2% formaldehyde (D-L) 4-5 days 
after passage.  129/SVEV mES cells were fixed with 
100% methanol (M-O) 2 days after passage.  Cells 
were co-labeled for and lamin A/C (C, F, I, L, and O) 
and the pluripotency markers Oct-4 (B, N), TRA-160 
(E), TRA-180 (H), and SSEA-4 (K).  Undifferentiated 
HSF-6 hES cells growing in a colony are positive for 
Oct-4 (B), TRA-160 (E), TRA-180 (H), and SSEA-4 
(L), but negative for lamin A/ C (C, F, I, and L).  
Conversely, adjacent differentiated CF-1 MEF feeder 
cells are negative for the pluripotency markers, but 
positive for lamin A/C.  Undifferentiated 129/SVEV 
mES cells within a colony are positive for Oct-4 (N), 
but negative for lamin A/C (O), whereas adjacent 
differentiated SNL MEF feeder cells are negative for 
Oct-4, but positive for lamin A/C.  DNA was visualized 
with TOTO-3 (A, D, G, J, and M).  Representative 
MEF feeder cells are identified with arrows.  Images 
were captured using confocal microscopy.  Scale bar 
equals 50 microns. 
  23
that are negative for Oct-4 labeling, contain lamin A/C.   Collectively, these observations indicate that 
 cells 
ns B1 
 
d 
e 
).  These results indicate that mouse and human ES cells express both B-type 
mins, although expression and/or protein levels may be lower than in differentiated cell types, and 
 
Our RT-PCR results from whole HSF-6 hES cell colony scrapings suggested that lamin A/C expression is  
undifferentiated ES cells do not express lamin A/C.   
 
2.4.2 Undifferentiated mES and hES cells express B-type lamins 
 
Next, we used RT-PCR analysis to investigate the expression of lamins B1 and B2 in HSF-6 hES
and report that HSF-6 hES cells express lamin B1 (Figure 4C, lane 2), but under the conditions utilized, 
we could not detect the presence of lamin B2 mRNA (Figure 4C, lane 2).  Immunocytochemistry 
experiments showed that undifferentiated HSF-6 hES cells and 129/SVEV mES cells contain lami
and B2 (Figure 6).  Since we previously demonstrated that undifferentiated HSF-6 hES cells and 
129/SVEV mES cells do not express lamin A/C, we utilized this feature along with morphological 
characteristics to identify undifferentiated ES cells.  Undifferentiated HSF-6 hES cells that are lamin A/C
negative (Figure 6B and E) express lamins B1 (Figure 6C) and B2 (Figure 6F).  Similarly, undifferentiate
129/SVEV mES cells that are lamin A/C negative (Figure 6H and K) express lamin B1 (Figure 6I) and 
lamin B2 (Figure 6L).  Interestingly, lamins B1 and B2 levels are low in HSF-6 hES cells relative to the 
differentiated CF-1 MEF feeder cells.  Further, lamin B2 is localized primarily at the nuclear envelope 
(Figure 7F), whereas lamin B1 demonstrates a peripheral and punctate labeling pattern throughout th
nucleoplasm, (Figure 7C
la
localization may differ. 
 
2.4.3 hES cells express A-type lamins upon differentiation to neuronal lineages and cardiomyocytes 
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activated in some peripheral hES cells, suggesting that expression is activated in differentiating cells.  
Further, some HSF-6 hES cell colonies that we examined exhibited peripheral cells that labeled for both 
Oct-4 (Figure 8B) and lamin A/C (Figure 8C) and probably represent cells that are beginning to 
differentiate.  To investigate this further, we used immunocytochemistry to examine if lamin A/C 
expression is activated in neuronal lineages and cardiomyocytes derived from HSF-6 hES cells.  
Neuronal cells as identified by either nestin (Figure 8E) or β-III tubulin (Figure 8H) labeled for lamin A/C 
(Figure 8F, I).  Similarly, beating cardiomyocytes, 
as identified by α-actinin (Figure 8K) or light 
meromyosin (MF 20) (Figure 8N), also 
demonstrated lamin A/C expression (Figure 8L, 
O).  Our results indicate that, upon differentiation 
to neuronal lineages and cardiomyocytes, hES 
cells begin to express lamin A/C.  Further, the 
detection of cells at the periphery of some HSF-6 
hES cell colonies that label for both Oct-4 and 
lamin A/C suggests that lamin A/C expression is 
activated prior to down-regulation of Oct-4 so that 
there is a transient overlap in expression.  We did 
not observe similar co-labeling of lamin A/C with 
Tra-1-60, Tra-1-81, and SSEA-4. 
Figure 6.  hES and mES cells contain lamin B1 and B2.  HSF-6 hES cells were fixed with methanol 5 days after 
passage.  Cells were co-labeled for lamin A/C (B, E, H, and K) in conjunction with either, lamin B1 (C, I), or lamin 
B2 (F, L).  Undifferentiated HSF-6 hES cells are negative for lamin A/C (B, E), but positive for lamin B1 (C) and B2 
(F).  Adjacent differentiated CF-1 MEF feeder cells, are positive for lamin A/C, lamin B1 and lamin B2.  Lamin B1 
(F) and B2 (I) levels are low in hES cells relative to the MEF feeder cells.  DNA was visualized with TOTO-3 (A, D, 
G, and J).  Representative MEF feeder cells are identified with arrows.  Images were captured using confocal 
microscopy.  Scale bar equals 50 microns (A-C and G-J) or 5 microns (D-F and J-L). 
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 Figure 7.  Lamins B1 and B2 localize primarily to the 
nuclear envelope of undifferentiated  hES cells.  
HSF-6 hES cells were co-labeled for lamin A/C (B, E) in 
and lamin B1 (C) or lamin B2 (F).  Undifferentiated HSF-
6 hES cells that are lamin A/C negative (B, E) exhibit low 
levels of lamins B1 (C) and B2 (F).  Lamin B2 is present 
primarily at the nuclear periphery (F).  Lamin B1 is 
present at the periphery as well as in punctate structures 
throughout the nucleoplam.  DNA was visualized with 
TOTO-3 (A, E).  Images were captured with confocal 
microscopy.  Scale bar equals 5 microns. 
 
 
 
 
2.5 DISCUSSION 
 
 
Nuclear lamins are components of the nuclear envelope that are involved in nuclear structural support 
and organization (Csoka et al., 2004a; Lammerding et al., 2004; Lenz-Bohme et al., 1997; Newport et al., 
1990; Smythe et al., 2000; Sullivan et al., 1999; Vigouroux et al., 2001), DNA replication (Moir et al., 
2000), transcription (Spann et al., 2002), and RNA processing (Jagatheesan et al., 1999; Muralikrishna et 
al., 2001).  B-type lamins are present in most cell types from the first zygotic cell division through  
adulthood (Rober et al., 1989).  In Contrast, A-type lamins are detected primarily in cells that are 
differentiated, as demonstrated by the lack of expression for the majority of mouse embryonic 
development (Rober et al., 1989), in various adult cells that are not fully differentiated (Rober et al., 
1989), and in EC cell lines (Peter and Nigg, 1991; Stewart and Burke, 1987).  The observation that B-type 
lamins are present in all cell types, but that A-type lamins are present primarily in differentiated cells 
suggests that A-type lamins could function to maintain the differentiated state.  To begin investigating this 
possibility, we examined lamin expression in embryonic stem cells and differentiated derivatives.  Since 
ES cells are isolated from blastocyst stage embryos and are pluripotent (Magnuson et al., 1982), we 
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hypothesized that undifferentiated ES cells should express B-type, but not A-type lamins, and that as ES 
cells differentiate lamin A/C expression would be 
activated.   
 
Using semi-quantitative RT-PCR with human-
specific primers, we show that undifferentiated 
HSF-6 cells express lamin B1 (Figure 4, lane 2), 
but lamin B2 (Figure 4, lane 2) could not be 
detected using two different sets of primers (only 
one shown).  Interestingly, immunocytochemistry 
analysis identified the presence of both lamin B1 
(Figure 6C, I) and B2 (Figure 6F, L) in HSF-6 hES 
and 129/SVEV mES cells.  However, HSF-6 hES 
cells appear to have lower B-type lamin levels 
relative to differentiated CF-1 MEF feeder cells.  
Further lamin B2 localization appears to be 
primarily peripheral with little or no labeling 
throughout the nucleoplasm (Figure 7F), whereas 
lamin B1 appears to be localized both to the 
periphery and in nuclear foci (Figure 7C).  This 
Figure 8. Lamin A/C is activated upon hES cell differentiation to neuronal lineages and cardiomyocytes.  
Some HSF-6 hES cell colonies contained peripheral cells that co-labeled for Oct-4 (B) and lamin A/C (C) with 
varying intensity.  HSF-6 hES cells were cultured for five weeks on CF-1 MEF feeder cells without passage to 
obtain neuronal lineages (D-I) and cardiomyocytes (J-O).  Differentiated cells were labeled for lamin A/C (F, I, L, 
and O) in conjunction with either nestin (E), β-III tubulin (H), α-actinin (K), or light meromyosin (MF-20) (N). DNA 
was labeled with TOTO-3 (A, D, G, J).  Neuronal lineages, as identified by nestin (E) or β-III tubulin (H), are positive 
for lamin A/C (F and I).  Cardiomyocytes, as identified by α-actinin (K), or light meromyosin (MF-20) (N), are 
positive for lamin A/C (L and O).  Images were captured with confocal microscopy.  Scale bars equal 25 microns. 
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suggests that although B-type lamins are present in HSF-6 hES cells, the nuclear lamina structure at the 
periphery and throughout the nucleoplasm is relatively under-developed.   
 
Our ability to detect lamin B2 protein using immunocytochemistry, but inability to detect lamin B2 mRNA 
using RT-PCR in HSF-6 hES cells seems contradictory.  Cross-reactivity of the lamin B2 antibody with 
lamin B1 is highly unlikely, since it has been shown that the antibody does not detect lamin B1 in western 
analysis (Lehner et al., 1986), so we hypothesize two alternative explanations.  First, lamin B2 mRNA 
might have a very short half-life, but sufficient protein accumulates for immunofluorescent detection.  
Second, hES cells might express a splice variant of lamin B2 that is recognized by the primary antibody, 
but lacks the region amplified by the PCR primers.  For example, lamin B3 is a significantly smaller splice 
variant of lamin B2 that so far has only been detected in male germ cells (Furukawa and Hotta, 1993).  
However, if such a splice variant is present in hES cells, it is unlikely to be lamin B3 because the region of 
lamin B2 amplified by the PCR primers is shared by lamin B3 (Furukawa and Hotta, 1993).  Therefore it is 
possible that hES cells express a unique, previously unidentified splice variant of lamin B2. 
Both RT-PCR and immunofluorescence analysis demonstrate that HSF-6 hES cells (Figure 3C, lane 2 
and Figure 5C, F, I, L) and 129/SVEV mES cells (Figure 5O) do not express lamin A/C.  Further, our 
results show that lamin A/C expression is activated in neuronal lineages (Figure 8F, I) and 
cardiomyocytes (Figure 8L, O) differentiated from HSF-6 hES cells.  This is consistent with previous 
reports that have detected lamin A/C only in differentiated cell types (Lourim and Lin, 1989b; Peter and 
Nigg, 1991; Prather et al., 1991; Prather et al., 1989; Rober et al., 1989; Schatten et al., 1985; Stewart 
and Burke, 1987).  Interestingly, cells at the periphery of some HSF-6 hES cell colonies, where 
spontaneous differentiation sometimes occurs (our observations), express both Oct-4 (Figure 8B) and 
lamin A/C (Figure 8C).  The intensity of Oct-4 and lamin A/C labeling varied within individual peripheral 
cells that had both present, but no statistically significant relationship could be established; we observed 
cells that had high intensity labeling for both, low intensity labeling for both, or high intensity for one and 
low intensity for the other.  The different combinations of Oct-4 and lamin A/C expression in individual 
cells suggests that either protein is not directly influenced by the other.  Interestingly, different Oct-4 to 
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lamin A/C ratios could represent cells undertaking alternate differentiation pathways.  Thus, it appears 
that lamin A/C is activated prior to complete Oct-4 down-regulation during the in vitro differentiation 
process, suggesting that lamin A/C expression is an earlier indicator of ES cell differentiation.  However, 
we did not observe similar co-labeling of lamin A/C with Tra-1-60, Tra-1-81, or SSEA-4, suggesting that 
these pluripotency markers are down-regulated before the activation of lamin A/C expression, in vitro. 
 
Taken together, our results identify the absence of A-type lamins as a novel marker of undifferentiated ES 
cells in culture and positive expression as an indicator of differentiation.  The presence of B-type lamins 
but absence of A-type lamins in ES cells demonstrates another similarity between ES cell lines and the 
inner cell mass cells from which they are derived.  However, during murine development, Oct-4 is down-
regulated in somatic tissues well before lamin A/C expression is detected in any cell type.  We describe 
lamin A/C expression prior to Oct-4 down-regulation in HSF-6 hES cells, suggesting that in vitro 
differentiation of ES cell lines might not mimic the consecutive steps that lead to tissue specification 
during embryonic development in vivo.  Lastly, our results are in accordance with a possible role for A-
type lamins in the maintenance of the differentiated state.   
 
How could A-type lamins maintain cells in a differentiated state?  Once expressed, A-type lamins could 
“lock” the nucleus of differentiated cells in particular gene expression patterns.  This would be a simple 
way to maintain transcriptional and phenotypic stability in specialized, terminally differentiated cells.  A-
type lamins could accomplish this by increasing nuclear rigidity, which could constrain chromatin 
remodeling.  Several lines of evidence support this possibility.  First, cells from patients with various 
LMNA mutations have an abnormally plastic nuclear morphology, marked by lobes and invaginations 
(Csoka et al., 2004a; Vigouroux et al., 2001).  Second, it has been directly shown that lamin A/C 
deficiency reduces nuclear structural integrity under mechanical strain (Lammerding et al., 2004).  Lastly, 
lamin A/C (Shoeman and Traub, 1990; Taniura et al., 1995) and lamin-associated proteins (LAPs) (Vlcek 
et al., 1999) can interact directly with chromatin by binding DNA directly, or via DNA associated proteins.  
Alternatively, lamin A/C could regulate the expression of specific genes that are involved in the 
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maintenance of a differentiated state as evidenced by observations that lamin A/C can interact with 
transcription factors such as MOK2 (Dreuillet et al., 2002) and SREBP1 (Lloyd et al., 2002), as well as 
retinoblastoma (Rb), which is involved in regulating cell cycle arrest and apoptosis (Johnson et al., 2004; 
Mancini et al., 1994; Ozaki et al., 1994).  Lamin A/C might also have widespread effects on gene 
expression, since proper lamin A/C organization may be essential for polymerase II dependent 
transcription (Kumaran et al., 2002; Spann et al., 2002), and it has been found to co-localize with splicing 
factor speckles (Jagatheesan et al., 1999; Kumaran et al., 2002; Muralikrishna et al., 2001).  The 
possibility should be considered that laminopathies arise because cells are unable to maintain their 
differentiated state as a result of a disorganized nuclear lamina caused by lamin A mutations.  Cellular 
dysdifferentiation, previously postulated as a cause of cancer and aging (Cutler, 1991; Kator et al., 1985; 
Kirkland et al., 2002) would result in abnormal gene expression, reduced proliferation, and/or apoptosis.  
The devastating premature aging disease, Hutchinson-Gilford Progeria Syndrome, could be the ultimate 
example of such dysdifferentiation. 
 
If A-type lamins maintain the differentiated state by “locking” cells in a specific gene expression pattern, 
whether directly through structural modification of the nuclear envelope or indirectly by influencing the 
expression of other genes, their absence in undifferentiated ES cells might be essential for pluripotentcy.  
The presence of a flexible nuclear envelope could be necessary for proper chromatin remodeling which 
occurs during differentiation.  Interestingly, the low levels and/or altered organization of B-type lamins 
observed in HSF-6 hES cells (Figure 6C, F and 7C, F) could also contribute to nuclear envelope flexibility.  
In such a scenario, forced expression of lamin A/C or increased B-type lamin expression might “lock” ES 
cells in their natural undifferentiated state.   
 
In conclusion, our results identify the lack of lamin A/C as a novel marker for undifferentiated ES cells, 
and lamin A/C expression as an early indicator of differentiation.  These observations support the 
hypothesis that lamin A/C has a functional role in the maintenance of the differentiated state.  Further, our 
results and the observation that undifferentiated ES have few nuclear pores (unpublisged data) suggests 
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that there are multiple structural differences between the nuclear envelopes of undifferentiated and 
differentiated cells that may be critical to the differentiation process.  
 
 
 
2.6 MATERIALS AND METHODS 
 
 
2.6.1 Cell Culture 
 
Mouse ES Cells:  129/SVEV mES cells (Specialty Media, Phillipsburgh) were maintained in an 
undifferentiated state by co-culture with mitomyocin (Sigma, St. Louis) -treated SNL mouse embryonic 
fibroblast (MEF) feeder cells (gift from Dr. Richard Chaillet, University of Pittsburgh) in DMEM medium 
with 15% FBS, 1% non-essential amino acids, 1mM L-Glutamine, 0.1mM β-mercaptoethanol, 1% 
nucleosides (all from Specialty Media), and 10^5 U/ml LIF (Chemicon, AU).  Cells were passaged every 
2-3 days and media was changed daily.  
 
Human ES cells: HSF-6 hES cells (from UCSF, San Francisco under license) were maintained in an 
undifferentiated state by co-culture with mitomyocin-treated CF-1 MEF feeder cells in DMEM medium with 
20% Knockout serum replacer, 1% non-essential amino acids, 1mM L-Glutamine, and 4ng/ml FGF-2 (all 
from Invitrogen, Carlsbad, CA).  Cells were passaged every 5-7 days and media was changed daily.  WI-
38 human embryonic lung fibroblasts (ATCC, Rockville, MD) were cultured in DMEM with15 % fetal 
bovine serum and 2mM L-Glutamine.  Neuronal lineages and cardiomyocytes were obtained by culture of 
HSF-6 hES for five weeks on CF-1 MEF feeder cells without passage.  Media were changed every 2 
days. 
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2.6.2 RNA Isolation and RT-PCR: 
 
The centers of undifferentiated HSF-6 colonies, cultured for 5 days under optimal conditions, were gently 
scraped with pulled pasteur pipets (see Figure 1A and B).  Whole colonies of HSF-6 cells, which had 
begun to naturally differentiate after ten days in culture, were scraped as well.  WI-38 cells were 
trypsinized.  All cells were spun at 200 x g for 5 min and then washed twice with PBS.  Cell pellets were 
immediately frozen in liquid nitrogen and stored at –80oC.  RNA was isolated using RNAqueous 4-PCR 
(Ambion, TX) and cDNA was generated using the Reverse Transcription System (Promega, WI) following 
the manufacturer’s instructions.  Spectrophotometry was used to verify quantity and quality of RNA and 
cDNA.  Semiquantitative PCR was performed with 50ng of cDNA in a final concentration of: 0.02 U 
Biolase DNA polymerase, 1X NH4 buffer, 2.5mM MgCl2 (Bioline, Randolph, MA), 0.2mM dNTPs (Roche), 
0.2μM primers (Invitrogen).  PCR conditions were: 95 oC for 3 min followed by 35 cycles at 95 oC for 35 
sec, 55 oC for 40 sec, and 72 oC for 45 sec and a final extension at 72 oC for 7 min.  Human specific 
primers used for each gene:  
Lamin A/C forward: AATGATCGCTTGGCGGTCTAC,   
Lamin A/C reverse: CTTCTTGGTATTGCGCGCTTT (255bp);   
Lamin B1 forward: AAAAGACAACTCTCGTCGCAT,   
Lamin B1 reverse: CCGCTTTCCTCTAGTTGTACG (256bp);   
Lamin B2 forward: ATTCAGAATCCAGGCGTCGAC,   
Lamin B2 reverse: TTATTGTTGTGACAGGTCTTACGACG (339bp);   
B-actin forward: TGGCACCACACCTTCTACAATGAGC,   
B-actin reverse: GCACAGCTTCTCCTTAATGTCACGC (400bp);   
Oct-4 forward: CGRGAAGCTGGAGAAGGAGAAGCTG,  
Oct-4 reverse: AAGGGCCGCAGCTTACACATGTTC (230bp). 
 
2.6.3 Wide-Field and Confocal Microscopy and Immunocytochemistry  
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hES and mES cells were passaged 4-5 days and 2 days, respectively, prior to fixation. Cells were fixed 
with 100% methanol for 20 minutes at –20°C or 2% formaldehyde for 45 minutes.  Cells were 
subsequently washed twice with PBS, permeabilized with 0.1% Triton X-100, and incubated for one hour 
at 25°C with combinations of the following primary antibodies: monoclonal mouse anti-human Oct-4 
(1:50), polyclonal rabbit anti-human lamin A/C (1:100) (both from Santa Cruz Biotechnology, Santa Cruz), 
monoclonal mouse anti-human lamin B1 (1:50) and B2 (1:50) (both from Zymed, San Francisco), 
monoclonal mouse anti-β-III tubulin (1:250), mouse anti-nestin (1:200) (both from Covance, Berkley), 
mouse anti-sarcomeric α-actinin (EA-53) (1:100) (from Sigma, Saint Louis), mouse anti-SSEA-4, mouse 
anti- TRA-160, mouse anti-TRA-180, and mouse anti-light meromyosin (MF-20) (1:3) (all obtained from 
the Developmental Studies Hybridoma Bank under the auspices of the NICHID, The University of Iowa, 
Department of Biological Sciences, Iowa City).  Cells were washed three times with PBS and the primary 
antibodies were detected with Alexa Fluor 488, Alexa Fluor 546, and Alexa Fluor 568 secondary 
antibodies (all 1:100) (all from Molecular Probes, Oregon) for one hour at 25°C.  DNA was visualized with 
TOTO-3 (1:1000) (Molecular Probes, Eugene), which was added to the secondary antibody mix.  Cells 
were washed three times in PBS and mounted onto glass slides with Vectashield mounting medium 
(Vector Laboratories, Burlingame).  Confocal images were captured with a Leica TCS SP2, using 
proprietary Leica software.   
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CHAPTER TWO: DEFECTIVE DOUBLE-STRAND BREAK REPAIR CORRELATES WITH ABNORMAL 
NUCLEAR MORPHOLOGY AND IS IMPROVED WITH FTI TREATMENT IN HUTCHINSON-GILFORD 
PROGERIA SYNDROME FIBROBLASTS. 
 
 
 
3.1. RATIONALE 
 
 
There are multiple lines of evidence indicating that HGPS cells exhibit elevated DNA damage levels. 
Firstly, HGPS cells demonstrate limited proliferative capacity in culture, early onset of senescence, and 
increased apoptosis rates (Bridger and Kill, 2004), all of which can be caused by DNA damage.  
Secondly, it has been shown that DNA damage response pathways exhibit elevated activity in HGPS 
cells (Liu et al., 2006; Varela et al., 2005).  Lastly, the most direct evidence of elevated DNA damage 
comes from a study that showed that HGPS have a DSB repair defect that may be specific to 
homologous recombination (HR) repair (Liu et al., 2005).  DNA damage accumulation due to 
compromised repair is a possible molecular mechanism responsible for the increased apoptosis rate and 
early onset of senescence observed in HGPS and in turn the accelerated aging phenotype.   
 
 
 
3.2. ABSTRACT 
 
 
Impaired DSB repair has been implicated as a molecular mechanism contributing to the accelerating 
aging phenotype in Hutchinson-Gilford Progeria Syndrome (HGPS), but neither the extent nor the cause 
of the repair deficiency have been fully elucidated.  Here we perform a quantitative analysis of the steady-
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state number of DSBs and the repair kinetics of IR-induced DSBs in HGPS cells.  We report a higher 
steady-state number of DSBs and impaired repair of IR-induced DSBs, both of which correlated strongly 
with abnormal nuclear morphology.  Expression of GFP-Progerin in human coronary artery endothelial 
cells (hCAECs) resulted in impaired repair of IR-induced DSBs which also correlated with abnormal 
nuclear morphology.  Farnesyl transferase inhibitor (FTI) treatment improved the repair of IR-induced 
DSBs, but only in HGPS cells whose nuclear morphology was also normalized.  Interestingly, FTI 
treatment did not result in a statistically significant reduction in the higher steady-state number of DSBs.  
There is also report a delay in localization of phospho-NBS1 and MRE11, MRN complex repair factors 
necessary for homologous recombination (HR) repair, to DSBs in HGPS cells.  Our results demonstrate a 
strong correlation between nuclear structural abnormalities and the DSB repair defect in HGPS and GFP-
Progerin positive cells, suggesting a mechanistic link that may involve delayed repair factor localization to 
DNA damage.  Further, our results show that similar to other HGPS phenotypes, FTI treatment has a 
beneficial effect on DSB repair. 
 
 
 
3.3. INTRODUCTION 
 
 
HGPS is a rare genetic disorder that causes rapid premature aging shortly after birth, recapitulating 
multiple pathologies associated with aging and resulting in a median lifespan of 13 years (Reviewed in 
[1]).  The disease is caused by de novo mutations within exon 11 of the LMNA gene which partially 
activate a cryptic splice donor site, resulting in deletion of 50 amino acids from exon 11, with subsequent 
production of a truncated form of lamin A termed, Progerin or lamin AD50 [2, 3].  LMNA encodes the A-
type nuclear lamins, primarily lamins A and C.  Along with the primary B-type lamins, lamin B1 and lamin 
B2, the A-type lamins form the nuclear lamina [4, 5], a scaffold-like structure that lines the inner nuclear 
membrane and also contribute to a nuclear matrix [6].  Multiple LMNA mutations produce nuclear 
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structural irregularities, demonstrating that A-type lamins are intricately involved in nuclear structural 
organization (Reviewed in [7]).  Furthermore, there are multiple lines of evidence indicating a central role 
for A-type lamins in chromatin organization (Reviewed in [7]). 
 
Accordingly, HGPS cells exhibit altered nuclear structural characteristics and chromatin organization.  
Nuclear structural irregularities include changes in the spatial distribution of nuclear pore complexes [8] 
as well modifications of the nuclear lamina [8, 9] that are likely responsible for the abnormal nuclear 
morphology observed in primary HGPS cells [2, 3, 8].  These structural irregularities are accompanied by 
functional changes, including reduced deformability of the nuclear lamina [9], increased nuclear stiffness 
and sensitivity to mechanical stress [10], and mitotic defects, including abnormal chromosome 
segregation, delays in cytokinesis and nuclear reassembly, and binucleation [11, 12].  Multiple chromatin 
organization changes have been described as well.  Particularly, HGPS cells exhibit loss of peripheral 
heterochromatin [8, 13] that may be due to epigenetic changes, including up-regulation of H3K9me3 and 
H4K20me3, which define constitutative heterochromatin and downregulation of H3K27me3 which defines 
facultative heterochromatin [13-15].  In addition to epigenetic changes, HP1a, which is usually associated 
with H3K9me3 is down-regulated and partially dissociated [14, 15].  It is likely that these abnormalities 
influence nuclear biological processes that dependent on proper nuclear structure and chromatin 
organization. 
 
It has been demonstrated that the nuclear morphological changes and altered chromatin characteristics 
are not caused by lamin A haploinsufficiency, but by the presence of Progerin in a dominant gain-of-
function fashion, possibly through its accumulation at the inner nuclear membrane (INM) [8, 14], where it 
appears to alter nuclear lamina structure [9].  In accordance, reduction of the farnesylated form of 
Progerin using farnesyl transferase inhibitors (FTIs) [16-22] and reduction of Progerin using antisense 
morpholinos [14] improves nuclear abnormalities in HGPS cells as well as various disease phenotypes in 
HGPS mouse models.  The success of FTIs in these studies and the current lack of any other therapeutic 
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approach for HGPS has lead to a current phase II clinical trial examining the beneficial effect of FTIs in 
HGPS patients (ClinicalTrials.gov identifier: NCT00425607). 
 
Interestingly, several lines of evidence indicate that HGPS cells have a higher steady-state number of 
DSBs.  HGPS cells demonstrate limited proliferative capacity in culture, early onset of senescence, and 
increased apoptosis [23], all of which can be caused by accumulation of DSBs.  Further, HGPS cells 
exhibit elevated activity of DNA damage response pathways [19]. Interestingly, the elevated activity of 
DNA damage response pathways was not reduced after 48 hours of FTI treatment even though nuclear 
morphology was improved, suggesting that the two phenotypes occur independently, and that FTIs may 
not be able to reduce the steady-state level of DSBs [19].  DSB accumulation appears to be due at least 
in part to impaired localization of DSB repair factors including, Rad51 and Rad50 [24].  It has also been 
shown that xeroderma pigmentosum group A (XPA), a nucleotide excision repair protein (NER), 
aberrantly localizes to a subset of DSBs in HGPS cells through interaction with chromatin and inhibits the 
localization of Rad51 and Rad50, perhaps through steric hindrance [24].  There is evidence to suggest 
that XPA does not localize to camptothecin (CPT) induced DSBs, indicating that XPA-localized DSBs 
may be functionally different in origin or repair [24].  However, XPA mediated interference with DSB repair 
does not fully explain the DSB repair problem in HGPS cells since repair of CPT-induced DSBs in HGPS 
cells is slower compared to wildtpye cells [24].   
 
In this study we performed a quantitative analysis of the steady-state number of DSBs and the repair 
kinetics of IR-induced DSBs in HGPS fibroblasts.  We also examined whether the observed deviations 
from wildtype for these characteristics correlated with abnormal nuclear morphology and were caused by 
Progerin.  Further, we examined whether FTI treatment can decrease the steady-state DSB level and 
improve the repair kinetics of IR-induced DSBs in HGPS cells.  Lastly, in order to expand on previous 
studies which showed that localization of repair factors to DSBs is impaired, we performed a quantitative 
analysis of the localization kinetics of the MRN repair complex factors, phospho-NBS1 and MRE1, to g-
irradiation induced DSBs.   
  37
3.4. RESULTS 
 
 
3.4.1. HGPS fibroblasts with an abnormal nuclear morphology have elevated steady-state levels of DSBs 
and demonstrate impaired repair of IR-induced DSBs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. HGPS fibroblasts exhibit limited proliferative capacity, abnormal nuclear morphology, and early 
onset of senescence.  A) Characterization of wildtype and HGPS fibroblast proliferation in culture for 38 days.  
B) HGPS cultures exhibited a higher percentage of cells with an abnormal nuclear morphology.  C) Light 
microscopy images of SA β-galactosidase activity, a marker of senescence, in wildtype (left two panels) and 
HGPS cultures (right two panels).  D) Quantification of the percentage of cells exhibiting SA β-galactosidase 
activity.  Scale bar equals 25 µm.   
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To investigate DNA damage repair in HGPS cells, we examined primary dermal fibroblasts derived from 
two HGPS patients (AG11513 and AG11498) and two apparently healthy individuals (AG08470 and 
AG16409) of similar age (Figure 15A).   Since there is evidence that HGPS cellular phenotypes increase 
in severity with increasing passage number [8], we used HGPS and wildtype cells of similar population 
doubling (Fig. 15A).  The HGPS fibroblasts used in these experiments display classical HGPS 
phenotypes including decreased proliferative capacity (Fig. 9A), abnormal nuclear morphology (Fig 9B), 
and increased (SA) β-galactosidase activity, indicating a higher percentage of senescent cells  (Fig. 9C, 
D). 
 
In order to examine the difference in the steady-state number of DSBs between HGPS and wildtype 
fibroblasts, we quantified the average number of DSBs per cell using the γ-H2AX foci assay.  H2AX is 
phosphorylated specifically at DSBs within minutes and is dephosphorylated after repair [25-28].  The 
formation and disappearance of γ-H2AX foci has been routinely used as a measure of DSB formation and 
repair, respectively [24-30].  A population of HGPS fibroblasts consists of cells that exhibit the 
characteristic abnormal nuclear morphology associated with HGPS, characterized by lobes and 
invaginations in the nuclear lamina, as well as cells that exhibit a normal nuclear morphology [8].  In order 
to examine whether the level of DSBs correlates with the abnormal nuclear morphology, we separated 
HGPS fibroblasts into two categories based on nuclear structure:  normal (HGPSN) and abnormal 
(HGPSAB) cells.  The nuclear envelope can be seen in the top panels in figure 10A using 
immunofluorescent labeling of lamin A, and whereas the nuclei in control cells are ovoid with the lamins 
circumscribing the inner nuclear surface, there are two types of nuclei in the HGPS fibroblasts:  normal 
nuclei that appear similar to wildtype (AG11513N and AG11498N) and others which display abnormal 
nuclear structure (AG11513AB and AG11498AB).  Although about 10% percent of AG08470 and 
AG16409 wildtype fibroblasts have an abnormal nuclear morphology (Fig. 9B), it is not due to the HGPS 
mutation, and thus we grouped together total wildtype cells irrespective of nuclear morphology  
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 Figure 10. Steady-state level of DSBs and repair kinetics of g-irradiation induced DSBs in HGPS fibroblasts.  
Immunocytochemistry was performed for γ-H2AX and lamin A/C in unirradiated cells and at 0.5, 2, 6, 12, 24, and 48 
hours after 2 Gy ionizing radiation.  A) Representative confocal immunofluorescent images of γ-H2AX foci (red) and 
DNA (blue) at representative timepoints after irradiation show easily identifiable γ-H2AX foci.   Lamin A/C (green) 
was included in the top row of panels to show the characteristic abnormal nuclear morphology that was used to 
differentiate between HGPS normal and abnormal cells.  AG11513N and AG11498N are HGPS fibroblasts 
exhibiting normal nuclear morphology.  AG11513AB and AG11498AB are HGPS fibroblasts exhibiting abnormal 
nuclear morphology.  B) γ-H2AX foci were visually detected and the average number of foci per cell was calculated 
for the indicated timepoints.  “T” = total cells including those with normal and abnormal nuclear morphologies.  “N” = 
cells with a normal morphology.  “AB” = cells with an abnormal morphology.  Data is form three different 
experiments.  At least 100 cells were examined per timepoint.  For statistical analysis, cells form multiple 
experiments were pooled together for each experimental group and a one-way ANOVA test was performed followed 
by a Tukey post-test to obtain p-values for the differences between specific pairs of means. Error bars represent the 
standard deviation (SD) of the number of γ-H2AX foci per cell in order to highlight the large variance from cell to cell.  
Confocal images were captured using a Leica TCS SP2 using Leica software.  Scale bar equals 10 µm.  * = p < 
0.05, ** = p < 0.01, and *** = p < 0.001. 
(AG08470T and AG16409T).  Averaged together, HGPSAB fibroblasts exhibited a 4.9-fold greater 
average number of γ-H2AX foci per cell compared to wildtype fibroblasts (Fig. 10B and 15B).  There was 
no statistically significant difference in the average number of γ-H2AX foci per cell between HGPSN and 
wildtype fibroblasts (Fig. 10B and 15B).   These results indicate that only HGPS cells with an  
abnormal nuclear morphology exhibit a higher steady-state average number of DSBs per cell compared 
to wildtype cells, demonstrating a correlation between the two phenotypes.   
 
The higher steady-state level of DSBs in HGPSAB fibroblasts could be due to an increased rate in DSB 
formation or to impaired DSB repair.  In order to test the latter hypothesis, we performed the γ-H2AX foci 
assay at 0.5, 2, 6, 12, 24, and 48 hours after irradiation to determine the kinetics of repair (Fig. 10).  As 
for unirradiated cells, we visually distinguished between HGPSN (Fig. 10A, middle two columns) and 
HGPSAB fibroblasts (Fig. 10A, right two columns) and grouped together total wildtype fibroblasts (Fig. 
10A, left two columns).  The average number of γ-H2AX foci per cell was quantified in figure 1B.  At 0.5 
hours after irradiation (Fig. 10B and 15B), which has been previously reported to reflect the apex of γ-
H2AX foci formation and represent the maximal number of DSBs formed [25, 26, 31], HGPSAB 
fibroblasts exhibited no statistically significant difference compared to wildtype and HGPSN fibroblasts, 
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indicating that H2AX phosphorylation occurs properly (Fig. 10B and 15B).   However, at 2, 6, 12, 24, and 
48 hours after irradiation, HGPSAB fibroblasts had a 1.5-fold, 3.1-fold, 2.7-fold, 3.9-fold, and 6.5-fold 
higher average number of γ-H2AX foci per cell compared to wildtype fibroblasts, respectively (Fig. 10B 
and 15B).  There was no statistically significant difference in the average number of γ-H2AX foci between 
HGPSN and wildtype fibroblasts at any timepoint after irradiation (Fig. 10B and 15B).  Further, whereas 
Figure 11.  HGPS cells exhibit persistent IR-induced DSBs.  Immunocytochemistry was performed for γ-H2AX and 
lamin A/C in unirradiated cells and at 0.5, 2, 6, 12, 24, and 442 hours after 2 Gy g-irradiation and the average 
number of γ-H2AX foci per cell was calculated. Examination of late repair kinetics shows that whereas wildtype 
fibroblasts (AG08470 and AG16409) return to steady-state DSB levels within 24 hours post-irradiation, HGPS 
cells continue to exhibit statistically significant higher levels of DSBs at 24 and 48 hours post-irradiation.  Data is 
form three different experiments.  At least 100 cells were examined per timepoint.  For statistical analysis, cells 
form multiple experiments were pooled together for each experimental group and a one-way ANOVA test was 
performed followed by a Tukey post-test to obtain p-values for the differences between specific pairs of means. 
Error bars represent the standard deviation (SD) of the number of γ-H2AX foci per cell in order to highlight the 
large variance from cell to cel.  * = p < 0.05, ** = p < 0.01, and *** = p < 0.001. 
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wildtype and HGPSN fibroblasts exhibited a return to steady-state DSB levels within 24 hours, HGPSAB 
fibroblasts still exhibited statistically significant differences even at 48 hours post-irradiation. (Fig. 11).  
These results indicate that repair of IR-induced DSBs is compromised specifically in HGPS cells with an 
abnormal nuclear morphology, highlighting a correlation between the two phenotypes. 
 
3.4.2. Impaired repair of IR-induced DSBs is due to production of Progerin and is present only in Progerin 
positive cells with an abnormal nuclear morphology. 
 
The abnormal nuclear morphology observed in HGPS cells is caused by the presence of Progerin in a 
dominant gain-of-function fashion [8, 15].  To examine whether Progerin is fundamentally responsible for 
the elevated steady-state number of DSBs and the impaired repair of IR-induced DSBs in HGPS cells, we 
expressed GFP-Progerin in normal hCAECs using lentiviral transduction (Fig. 12A, right columns).  We 
also expressed GFP-LMNA to control for overexpression of a lamin A-like protein (Fig. 12A; middle left 
column).  Expression of GFP-Progerin resulted in GFP-Progerin positive hCAECs with normal (Fig. 12A, 
middle right column) or abnormal nuclear morphologies (Fig 12A, right column) similar to what is seen in 
HGPS fibroblasts.  Expression of GFP-LMNA had little to no effect on nuclear morphology (Fig. 12A, 
middle left column), similar to previous reports [8].  As before, we categorized GFP-Progerin positive 
hCAECs as having normal (GFP-HGPSN) or abnormal (GFP-HGPSAB) nuclear morphology.  
Unirradiated GFP-HGPSAB cells exhibited a 4.9-fold higher average number of γ-H2AX foci per cell 
compared to wildtype cells (Fig. 12B and 15C), indicating that expression of GFP-Progerin increases the 
higher steady-state number of DSBs.  Analysis of the repair of IR-induced DSBs shows that expression of 
GFP-Progerin in wildtype hCAECs compromises DSB repair.  At 0.5 hours post-irradiation, all cell types 
had a similar average number of γ-H2AX foci per cell (Fig. 12B, and 15C), indicating that GFP-Progerin 
has no effect on H2AX phosphorylation.  At 12 and 24 hours post-irradiation GFP-HGPSAB cells 
exhibited a 2-fold and 4.3-fold higher average number of γ-H2AX foci per cell compared to wildtype cells 
(Fig. 12B and 15C), indicating that GFP-Progerin interferes with repair of IR-induced DSBs.  There was 
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no statistically significant difference between wildtype and GFP-HGPSN cells (Fig. 12B and 15C), 
indicating that steady-state DSB levels were elevated and DSB repair was compromised only in cells 
whose nuclear morphology was altered. Further, no statistically significant differences were detected 
between wildtype and GFP-LMNA positive cells (Fig. 12B and 15C), indicating that overexpression of 
lamin A had little or no effect on DSB repair.  Altogether, these results indicate that Progerin is 
fundamentally responsible for the elevated steady-state levels of DSBs and defective repair of IR-induced 
DSBs in HGPS in a dominant gain-of-function manner and that both phenotypes strongly correlate with 
the abnormal nuclear morphology. 
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 Figure 12.  GFP-Progerin expression 
increases the steady-state level of DSBs 
and impairs repair of IR-induced DSBs in 
normal hCAECs.  A)  Immunocytochemistry 
was used to examine wildtype, GFP-LMNA 
positive, GFP-HGPSN positive (normal 
nuclear morphology), and GFP-HGPSAB 
positive (abnormal nuclear morphology) 
hCAECs for γ-H2AX (red).  GFP 
fluorescence was captured (green).  Stable 
expression of the GFP constructs was 
achieved using lentiviral transduction.  Only 
GFP-Progerin positive cells were 
examined.  B) γ-H2AX foci were visually 
detected and the average number of foci 
per cell was calculated for the indicated 
timepoints.  Data is from two different 
experiments. At least 50 cells were 
examined per timepoint.  For statistical 
analysis, cells form multiple experiments 
were pooled together for each experimental 
group and a one-way ANOVA test was 
performed followed by a Tukey post-test to 
obtain p-values for the differences between 
specific pairs of means. Error bars 
represent the standard deviation (SD) of 
the number of γ-H2AX foci per cell in order 
to highlight the large variance from cell to 
cell.Confocal images were captured using a 
Leica TCS SP2 using Leica software.  
Scale bar equals 10 µm.  * = p < 0.05, ** = 
p < 0.01, and *** = p < 0.001. 
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3.4.3. FTI treatment improves nuclear morphology and repair of IR-induced DSBs, but does not reduce 
the steady-state level of DSBs in HGPS fibroblasts.  
 
FTI treatment, which inhibits the maturation of Progerin, improves some of the nuclear abnormalities 
associated with HGPS both in vitro and in animal models [16-22]. To examine whether FTI treatment 
reduces steady-state DSB levels, we quantified the average number of γ-H2AX foci per cell after 72 hours 
of treatment.  To examine whether FTI treatment improves the repair kinetics of IR-induced DSBs, we 
quantified the average number of γ-H2AX foci per cell at 0.5, 24, and 48 hours post-irradiation.  For this 
purpose, FTI treatment was initiated 72 hours prior to irradiation and continued until the cells were 
assayed with cells examined 24 and 48 hours post-irradiation receiving a total of 96 and 120 hours of FTI 
treatment, respectively.    
 
First, FTI treatment resulted in a statistically significant reduction in the percentage of HGPS fibroblasts 
with an abnormal nuclear morphology, as determined using immunofluorescence microscopy to visualize 
lamin A/C (Fig. 13A and 15D), similar to previous reports [16, 17, 22].  The decrease in the percentage of 
cells with an abnormal morphology correlated with the length of FTI treatment.  Unirradiated FTI-treated 
AG11513 and AG11498 HGPS fibroblasts (72 hours total treatment) exhibited a 36% and 41% reduction 
in the percentage of cells with an abnormal nuclear morphology, respectively compared to non-treated 
cells (Fig. 13A, white bars).  FTI-treated AG11513 and AG11498 fibroblasts examined 24 hours post-
irradiation  (96 hours total treatment) showed a 39% and 44% reduction, respectively (Figure 13A, gray 
bars).  FTI-treated AG11513 and AG11498 fibroblasts examined 48 hours post-irradiation (120 hours total 
treatment) showed a 49% and 47% reduction, respectively (Fig. 13A, black bars).  The percentage of FTI-
treated HGPS fibroblasts with abnormal nuclear morphology remained statistically higher than wildtype 
fibroblasts for unirradiated cells as well as cells examined post-irradiation, indicating that FTI treatment 
does not restore normal morphology to all HGPS fibroblasts in the time periods examined, consistent with 
other reports [16, 17, 22]. 
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To analyze the effect of FTI treatment on the steady-state level of DSBs and repair of IR- induced DSBs 
in HGPS cells, we used total HGPS (HGPST) cells instead of distinguishing between those with normal 
and abnormal morphology because FTIs improve nuclear morphology, which we have shown is 
correlated with the DSB repair defect and may cause erroneous interpretation of the results.  First, 
grouping HGPS cells with normal and abnormal morphologies together still resulted in a statistically 
significant higher average number of γ-H2AX foci per cell compared to wildtype cells, for both unirradiated 
cells and cells examined 24 and 48 hours post irradiation (Fig 13B and 15E).  Averaged together, HGPST 
fibroblast cultures exhibited a 3.2–fold higher steady-state average number of γ-H2AX foci per cell 
compared to wildtype cultures (Fig 13B and 15E).  After irradiation, no statistically significant differences 
were observed at 0.5 hours between HGPST and wildtype cultures, but HGPST cultures did exhibit 2.15–
fold and 2.3–fold higher average numbers of γ-H2AX foci per cell at 24 and 48 hours after irradiation, 
respectively (Fig 13B and 15E).  
Figure 13.  FTI treatment improves nuclear morphology and repair of IR-induced DSBs in HGPS fibroblasts, but 
has no effect on the steady-state level of DSBs.  HGPS cells and cells from healthy individuals were treated for 72 
hours with 5 uM FTI L-744832.  Cells used in irradiation studies were treated with the FTI post-irradiation until 
assayed. Immunocytochemistry was performed for γ-H2AX and lamin A at the indicated timepoints after 2 Gy g-
irradiation.  A) Percentage of unirradiated (white bars), 24 hrs. post-irradiation (gray bars), and 48 hrs. post-
irradiation (black bars) fibroblasts exhibiting an abnormal nuclear morphology in the presence (+) or absence (-) of 
FTI.  Data is from experiments.  At least 200 total cells were examined per group.  Error bars represent the 
standard error of the mean (SEM). B) Examination of the average number of γ-H2AX foci per cell shows a 
statistically significant reduction in FTI-treated HGPS cells at 24 and 48 hours post-irradiation compared to non-
treated HGPS cells.  The differences between FTI-treated and non-treated unirradiated HGPS cells were not 
statistically significant.  “T” = total cells including those with normal and abnormal nuclear morphologies.  “TFTI” = 
FTI-treated total cells including those with normal and abnormal nuclear morphologies.  D) Examination of the 
average number of γ-H2AX foci shows no change in HGPSN and HGPSAB populations after FTI treatment, 
suggesting that the overall decrease in HGPS cells is due to correction of the nuclear morphology defect. “N” = 
cells with normal nuclear morphology.  “NFTI” = FTI-treated cells with normal morphology.  “AB” = cells with 
abnormal nuclear morphology.  “ABFTI” = FTI-treated cells with abnormal nuclear morphology. The data 
presented in B and C were obtained from three experiments. For statistical analysis, cells form multiple 
experiments were pooled together for each experimental group and a one-way ANOVA test was performed 
followed by a Tukey post-test to obtain p-values for the differences between specific pairs of means. Error bars 
represent the standard deviation (SD) of the number of γ-H2AX foci per cell in order to highlight the large variance 
from cell to cell.  Confocal images were captured using a Leica TCS SP2 using Leica software.  * = p < 0.05, ** = p 
< 0.01, and *** = p < 0.001. 
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Quantification of the average number of γ-H2AX foci per cell for unirradiated FTI-treated HGPST 
(AG11513TFTI and AG11498TFTI) fibroblasts resulted in a statistically insignificant reduction compared 
to untreated HGPST (AG11513T and AG11498T) fibroblasts (Fig. 13B and 15E).  This indicates that FTI 
treatment for 72 hours does not result in a detectable reduction in the steady-state number of DSBs in 
HGPST fibroblasts under our experimental conditions.  At 0.5 hours after irradiation there was no 
statistically significant difference in the average number of IR-induced γ-H2AX foci between FTI-treated 
and non-treated HGPST fibroblasts (AG11513T and AG11498T) (Fig 13B and 15E).  However, at 24 and 
48 hours post-irradiation, FTI-treated HGPST fibroblasts (AG11513TFTI and AG11498TFTI) exhibited a 
statistically significant reduction in the average number of IR-induced γ-H2AX foci per cell compared to 
non-treated HGPST fibroblasts (AG11513T and AG11498T) (Fig. 13B and 15E), indicating that FTI 
treatment for 96 or 120 hours improves DSB repair.  The differences in the average number of γ-H2AX 
foci per cell for FTI-treated HGPS fibroblasts (AG11513TFTI and AG11498TFTI) and wildtype fibroblasts 
were not statistically significant at 24 and 48 hours after irradiation under our experimental conditions 
(Fig. 13B and 15E), indicating that FTI treatment improves repair of IR-induced DSBs in HGPST 
fibroblasts to an efficiency that is indistinguishable from wildtype cells.  Altogether, these results indicate 
that although FTI treatment can improve repair of IR-induced DSBs, it may not be able to reduce the 
steady-state level of DSBs in HGPS cells.   
 
We hypothesized that the improvement in repair of IR-induced DSBs in HGPST cells may represent an 
improvement in all cells independent of nuclear morphology or may occur specifically in cells whose 
nuclear morphology was normalized.  The latter hypothesis is supported by our earlier results, which 
indicate a correlation between abnormal nuclear morphology and impaired repair of IR-induced DSBs.  If 
there is no correlation between abnormal nuclear morphology and the DSB repair defect, we would 
expect to see the following two outcomes:  First, we would expect to see an FTI-dependent reduction in 
the average number of γ-H2AX foci per cell in HGPSAB fibroblasts due to individual HGPSAB fibroblasts 
that experience an improvement in DSB repair, but not in nuclear morphology.  We did not observe this; 
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FTI-treated HGPSAB fibroblasts exhibited the same average number of γ-H2AX foci per cell as the non-
treated HGPSAB fibroblasts (Fig. 13C and 15F), indicating that improvement in DSB repair only occurred 
in cells whose nuclear morphology was normalized.  Second, we would expect to see an FTI-dependent 
increase in the average number of γ-H2AX foci per cell in HGPSN fibroblasts due to individual HGPSAB 
fibroblasts that experience an improvement in nuclear morphology, but not in DSB repair.  We did not 
observe this either; FTI-treated HGPSN fibroblasts exhibited the same average number of γ-H2AX foci 
per cell as non-treated HGPSN fibroblasts (Fig. 13C and 15F), indicating that normalization of nuclear 
morphology was always accompanied by an improvement in DSB repair.  These results demonstrate a 
strong correlation between nuclear morphology normalization and improvement in repair of IR-induced 
DSBs after FTI treatment.  
 
 
3.4.4. MRN repair complex factor localization to IR-induced DSBs is delayed in HGPST cells and GFP-
Progerin positive hCAECs with an abnormal nuclear morphology. 
 
 
Previous reports suggest that the DSB repair deficiency observed in HGPS cells is specific to HR repair 
[29].  It has been reported that the localization of the DSB repair factors, Rad50 and Rad51 to XPA-
localized DSBs is impaired in HGPS cells due to the aberrant localization of XPA, possibly through steric 
hindrance [24].  However, the localization of repair factors to IR-induced DSBs has not been clearly 
investigated in HGPS cells.  Since the MRN (MRE11/Rad50/phospho-NBS1) repair complex is essential 
for DSB HR repair (Reviewed in [32]), we examined the protein levels of NBS1 and MRE11 as well as 
their colocalization kinetics to IR-induced γ-H2AX foci in total HGPS cells as well as GFP-Progerin 
positive hCAECs with an abnormal nuclear morphology (Fig. 14 and 15F,G).  Immunocytochemistry was 
used to examine colocalization, identified by overlap of γ-H2AX shown in red and either phospho-NBS1 
(Fig 14A) or MRE11 (Fig. 14B) shown in green.  The percent of γ-H2AX foci that have either phospho-
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NBS1 (Fig. 14C and 15G) or MRE11 (Fig 14D and 15H) colocalized at 0.5 and 2 hours post-irradiation 
was calculated.  HGPS AG11513T (77%) and AG11498T (79%) fibroblasts and GFP-Progerin expressing 
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hCAECs with an abnormal nuclear morphology (75%) exhibited statistically significant lower percentages 
of γ-H2AX foci colocalized with phospho-NBS1 at 0.5 hours after irradiation compared to wildtype 
AG08470T (93%) and AG16409T (92%) fibroblasts and wildtype hCAECs (92%) (Fig. 14C and 15G).  
Similarly, HGPS AG11513T (62%) and AG11498T (61%) fibroblasts and GFP-Progerin expressing 
hCAECs with an abnormal nuclear morphology (58%) exhibited a statistically significant lower  
percentage of γ-H2AX foci colocalized with MRE11 at 0.5hrs. post-irradiation compared to wildtype 
AG08470 (93%) and AG16409 (92%) fibroblasts and wildtype hCAECs (92%) (Fig. 14D and 15H).  The 
differences in colocalization between HGPST fibroblasts and wildtype fibroblasts as well as between 
GFP-Progerin positive hCAECs with abnormal nuclear morphology and wildtype hCAECs disappeared by 
two hours after irradiation for both phospho-NBS1 (Fig. 14C and 15G) and MRE11 (Fig. 14D and 15H).  
Western blot analysis showed no substantial differences in the protein levels of total NBS1 and MRE11 
between wildtype and HGPS fibroblasts (Fig. 14E).  Altogether these results indicate that phospho-NBS1 
and MRE11 localization to IR-induced DSBs may be delayed by as much as 2 hours.  It is important to 
note that total HGPS cells were examined so the localization defect is likely to be even greater for HGPS 
cells with an abnormal nuclear morphology.  Lastly, the observation that only select DSBs exhibit a lack of 
colocalization at 0.5 hours post-irradiation suggests that the delay only occurs at particular DSBs and is 
not a general phenomenon throughout the entire nucleus.   
Figure 14.  MRN repair complex factors exhibit delayed localization to IR-induced DSBs in total HGPS fibroblasts 
and GFP-Progerin expressing hCAECs with an abnormal nuclear morphology.  Immunocytochemistry was 
performed for γ-H2AX and either phospho-NBS1 or MRE11 at various timepoints after g-irradiation and the 
percentage of γ-H2AX foci exhibiting phospho-NBS1 or MRE11 colocalization was determined. A) 
Immunocytochemistry for γ-H2AX (green) and phospho-NBS1 (red).  B) Percentage of γ-H2AX foci exhibiting 
phospho-NBS1 colocalization. C) Immunocytochemistry for γ-H2AX (green) and MRE11 (red).  D) Percentage of 
γ-H2AX foci exhibiting MRE11 colocalization.  E) Western analysis of total NBS1 and MRE11.  Data is from two 
experiments. Three experiments were performed.  At least 1000 foci were examined for each timepoint. For 
statistical analysis, cells form multiple experiments were pooled together for each experimental group and a one-
way ANOVA test was performed followed by a Tukey post-test to obtain p-values for the differences between 
specific pairs of means.  Error bars represent the standard deviation (SD) in the percentage of γ-H2AX foci with 
phospho-NBS1 or MRE11 colocalized per cell.  Confocal images were captured using a Leica TCS SP2 using 
Leica software.  Scale bar equals 5 µm. * = p < 0.05, ** = p < 0.01, and *** = p < 0.001 
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 Figure 15.  A) Cell type used in experiments: primary dermal fibroblasts of similar population doubling from age-
matched healthy individuals (AG08470 and AG16409) and HGPS patients (AG08470 and AG11409). B-G) 
Tables providing exact values and standard deviations or standard errors as indicated in the figure legends for 
each figure as referenced in the text.  B = Figure 10, C = Figure 12, D = Figure 13A. E = Figure 13B, F = Figure 
13C.  G = Figure 14C, and H = Figure 14B. 
 
 
3.5. DISCUSSION 
 
 
Recent reports have demonstrated an accumulation of DSBs in HGPS cells which may be due to 
defective DSB repair [19, 24, 29, 30].  These observations are interesting since DNA damage 
accumulation may contribute to the increased levels of apoptosis and senescence observed in HGPS 
cells and in turn to the accelerated aging phenotype.  Here, we set forth to examine the severity of the 
DSB repair defect and investigate the mechanism/s responsible.  Quantitative analysis showed that 
HGPS fibroblasts exhibit a higher steady-state number of DSBs and impaired repair of IR-induced DSBs 
compared to wildtype fibroblasts (Fig. 13B and 15E).   The higher steady-state level of DSBs may be 
responsible for the elevated DNA damage signaling pathways reported in HGPS cells [19]. Our results 
are in accordance with two recent studies which showed that HGPS cells exhibit a higher steady-state 
level of DSBs [30].  Sedelnikova et al. reported that the average number of γ-H2AX foci per cell increases 
with passage in cultures.  The authors detected 1.0, 1.2, and 1.9 average γ-H2AX foci per cell at passage 
15, 26, and 38, respectively.  Liu et al. also recently reported that passage 16 AG11513A HGPS primary 
fibroblast cultures exhibited about 10 average γ-H2AX foci per cell [24].  Our detection of 0.5 foci and 0.43 
foci per cell for AG11513 and AG11498 HGPS cell cultures at passage 8-9 is in close agreement with the 
results obtained by Sedelnikova et al.   
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Ecoptic expression of GFP-Progerin in wildtype hCAECs produced similar phenotypes to HGPS primary 
fibroblast cultures.  GFP Progerin positive cells displayed an increased steady-state level of DSBs (Fig 
12A,B and 15C) and impaired repair of IR-induced DSBs (Figure 12A,B and 15C).  In contrast, 
expression of a control GFP-LMNA construct resulted in minimal nuclear morphological changes and did 
not result in a statistically significant increase in steady-state DSB levels or a detectable defect in repair of 
IR-induced DSBs.  This indicates that Progerin is fundamentally responsible for both phenotypes in a 
dominant gain-of-function manner similar to other HGPS cellular phenotypes [8, 14].   
 
Separation of HGPS and GFP-Porgerin positive cells into groups with “normal” (N) or “abnormal” (AB) 
nuclear morphologies showed that the elevated steady-state level of DSBs and the DSB repair defect are 
only present in cells with an abnormal nuclear morphology (Fig 10A,B and 15B; Fig 12A,B and 15C).  The 
strong correlation between the DSB associated defects and the abnormal nuclear morphology highlights 
the possibility of a mechanistic link even though it is possible that the two phenotypes occur 
independently through separate Progerin-dependent mechanisms.  If there is a mechanistic link it is 
theoretically possible that the DSB-associated defects cause the abnormal nuclear morphology.  
However, this scenario is extremely unlikely because we did not observe any nuclear morphological 
changes similar to HGPS in wildtype fibroblasts in response to IR-induced DSBs.  Further, there is no 
report to our knowledge suggesting that DSB formation leads to nuclear morphological changes similar to 
HGPS.  Apoptosis, which can be caused by elevated levels of DSBs, does result in nuclear morphological 
changes, including chromatin condensation, nuclear shrinkage, and formation of apoptotic bodies, but 
these processes are characterized by a unique and different morphological pattern (Reviewed in [33]).  
Alternatively, the nuclear structural irregularities that underlie the abnormal nuclear morphology may 
cause the DSB repair defect.  This last possibility is intriguing since it is becoming clear that the nucleus is 
a highly ordered compartment and that nuclear structure and chromatin organization are intricately linked 
to nuclear biological processes (Reviewed in [34, 35]). 
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How can nuclear structural irregularities impair DSB repair?  Our observation along with those of others 
[24] which show that DSB repair factor localization to DSBs is compromised in HGPS cells highlights the 
possibility that abnormal nuclear structure impairs DSB repair by interfering with repair factor localization.  
We examined the kinetics of phospho-NBS1 (Fig. 14A,C and 15G) and MRE11 (Fig 14B,D and 15H) 
colocalization to IR-induced DSBs, and observed that both DSB repair factors exhibit an initial delay in 
localization to particular DSBs in HGPST cells.  However, by two hours post-irradiation, both repair 
factors were localized to a similar percentage of DSBs in HGPST and wildtype cells.  NBS1 and MRE11 
protein levels were comparable in HGPS and wildtype cells.  Similar colocalization delays to IR-induced 
DSBs were obtained in hCAECs expressing Progerin-GFP.  There are multiple theoretical ways in which 
abnormal nuclear structure can interfere with DSB repair factor colocalization.  First, the nuclear lobes 
and invaginations present in the nuclear envelope may compartmentalize the nucleus and thus restrict 
the motility or accessibility of repair factors to particular DSBs.  A second possibility is that the local 
nuclear matrix which may be necessary for the formation of functional multi-protein repair complexes, and 
to which lamins have been proposed to contribute [6] is disrupted by the presence of Progerin.  Third, 
local chromatin organization, which appears to be altered in HGPS cells [8, 15], may interfere with the 
formation of functional repair complexes. Interestingly, the changes in chromatin organization may 
themselves be due to more fundamental irregularities in nuclear structure.  These scenarios could render 
local regions of the nucleus unfavorable to DSB repair, and DSBs that randomly occur in unfavorable 
regions may experience delayed or incomplete repair.   
 
Interestingly, it has been recently proposed that among the multiple roles the MRN complex has in DSB 
repair is a tethering function that acts in two ways.  First, the MRN complex tethers the two ends of the 
broken chromosome together and second, it also tethers the broken chromosome to the sister chromatid 
or other homologous genomic region that is to be used for homologous recombination repair (Reviewed 
in [32]).  It is easily conceivable that a delay in the formation of such tethering units may lead to 
separation of the broken ends at a DSB, which may slow down or preclude further repair. 
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How can the accumulation of DSBs lead to the accelerated aging phenotype observed at the organismal 
level in HGPS?  First, the prolonged presence of individual DSBs can activate DNA damage response 
pathways whose activity levels have been shown to be elevated in HGPS cells [19, 36].  Hyperactive 
DNA damage response pathways can lead to higher rates of apoptosis and senescence which have also 
been reported in HGPS cells.  Even a delay of 1-2 hours as observed for phospho-NBS1 and MRE11 
localization may be sufficient to lead to apoptosis or senescence.  The importance of early response to 
DNA damage for cell survival is highlighted by a recent study, which showed that the radiosensitization 
caused by a one hour delay in activation of ATM after g-irradiation accounts for 70% of the 
radiosensitization caused by a 17 hour delay [37].   Finally, higher levels of apoptosis and senescence 
can lead to accelerated tissue/organ degeneration over time perhaps in part through exhaustion of adult 
stem cell pools as has been proposed (Reviewed in [38]). 
 
We also demonstrate that FTI treatment, which has been shown to improve multiple HGPS phenotypes 
[16-22], also improves repair of IR-induced DSBs in HGPS cells.  Interestingly, although we observed a 
reduction in the steady-state average number of DSBs per cell (non-IR-induced), it was not statistically 
significant, indicating that FTI treatment may not be able to reduce the level of steady-state DSBs.  This 
observation is consistent with a previous report, which showed that FTI treatment did not reduce the 
elevated levels of DNA damage signaling pathways in HGPS cells [19].  There are several possible 
explanations for the discrepancy in the effect of FTI treatment on the repair of IR-induced DSBs and 
steady-state DSB levels.  One possibility is that irradiated cells underwent longer FTI treatment (as 
described in the materials and methods) which may have resulted a greater beneficial effect on DSB 
repair.  Another possible explanation is that FTI treatment creates a nuclear environment in which novel-
DSBs (IR-induced) undergo normal repair, but pre-existing DSBs that formed in the context of nuclear 
structural irregularities remain irreparable.  Lastly, there is evidence to suggest that some endogenous 
DSBs in HGPS cells  (those observed at steady-state) appear to have XPA aberrantly localized and may 
be functionally different in origin and/or repair from those induced ectopically [24].  In this scenario, it is 
possible that FTIs improve the repair of ectopically-induced DSBs, but that the presence of XPA or other 
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characteristics of particular engogenous DSBs detected in non-irradiated cells may resist the FTI-based 
improvement.  Further investigation is necessary to elucidate this matter.  Such investigation is essential 
because if FTIs do not improve endogenously occurring DSBs in HGPS cells, then FTI treatment may not 
have significant clinical benefit. 
 
HGPS research is motivated by the objective to develop therapeutic approaches for individuals with 
HGPS as well as by the rationale that the mechanism/s underlying the accelerated aging phenotype will 
increase our understanding of normal aging and age-associated disease.  Regarding the former, our 
findings offer mixed results.  On the one hand we show that FTI treatment can improve the DSB repair of 
radiologically-induced DSBs in HGPS cells.  On the other hand, our results and those of others suggest 
that a subset of endogenously occurring DSBs (XPA-localized) may be functionally distinct and resistant 
to FTI-based repair improvement.  In terms of HGPS research expanding our understanding of normal 
aging, our results suggest that, similar to other progeroid syndromes, HGPS pathology occurs due to an 
amplification of a biological process already believed to contribute to normal aging, namely DNA damage 
accumulation.  The possibility that DNA damage accumulation is amplified by nuclear structural 
irregularities, as identified by our results, suggests that maintenance of proper nuclear structural 
organization is important for longevity.   
 
 
 
 
3.6. MATERIAL AND METHODS 
 
 
3.6.1. Cell Culture 
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Primary dermal fibroblasts, AG80470, AG16409, AG11513, and AG11498 (Coriell Cell Repository; 
Camden, NJ) were grown in Dulbecco’s modified Eagles’s medium (DMEM) supplemented with 15% fetal 
bovine serum, 1mM L-glutamine, 1% Pen/Strep, 1% MEM Non-essential amino acids.  Cells were 
passaged every 4-6 days and media was changed every 2 days.  Primary human coronary artery 
endothelial cells (Cambrex; East Rutherford, NJ) were cultured in endothelial cell basal medium (EBM) 
supplemented with the EGM-MV bullet kit (Cambrex).  Cells were passaged every 6-8 days and media 
changed every 2 days. 
 
3.6.2. FTI treatment 
 
Cells were passaged and the media was replaced 24 hours later with media containing 5 uM FTI L-
744832 (Biomol, Plymouth Meeting, PA).  FTI media was replaced every 24 hours for 72 hours as 
described.  For irradiated cells, treatment was continued every 24 hours post-irradiation until cells were 
assayed. 
 
3.6.3. Western Analysis 
 
Western immunoblotting was performed according to established protocols.  Briefly, 10ug of protein was 
loaded onto Tris-HCL 4-15% linear gradient gels (Bio-Rad Laboratories; Hercules, CA) and individual gels 
were run at 60mA, 200V.  Proteins were transferred to PVDF membrane for one hour at 350mA, 100V. 
PVDF membrane was blocked for one hour in Tris-Buffered Saline (TBS) containing 5% non-fat dry milk 
and 0.1% Tween-20.  The following primary antibodies were diluted in blocking solution and used as 
needed: mouse anti-human MRE-11 monoclonal antibody (Novus Biologicals; Littleton, CO) and rabbit 
anti-human NBS1 polyclonal antibody (Millipore; Billerica, MA).  Anti-mouse (Zymed Laboratories; San 
Francisco, CA) and anti-rabbit (Invitrogen; Carlsbad, CA) HRP-conjugated goat secondary antibodies 
were used and detected via chemi-luminescence using an ECL Advance Western Blotting Detection Kit 
(GE Healthcare; Buckinghamshire, UK). 
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3.6.4. Immunocytochemistry 
 
Briefly, cells were passaged onto glass slides and fixed using –20°C methanol or 2% paraformaldehyde, 
as appropriate.  The cells were washed 2X in PBS and 1X in Triton-X PBS and blocked for 30 minutes in 
BSA(0.3%)/goat serum(5%) at room temperature.  Cells were then incubated with the following primary 
antibodies were as needed for one hour at room temperature: rabbit anti-human (pS353) polyclonal 
antibody, mouse anti-human MRE-11 monoclonal antibody, rabbit anti-human γ -H2AX polyclonal 
antibody (Novus Biologicals; Littleton, CO), mouse-anti-human γ -H2AX monoclonal antibody (Upstate; 
Lake Placid, NY). The cells were washed 2X in PBS and 1X in Triton-X PBS.  The cells were incubated 
with anti-mouse and anti-rabbit Alexa fluor-488, -568, -633 secondary antibodies as appropriate 
(Molecular Probes; Eugene, Oregon).  DNA was visualized with TOTO-3 as needed (Molecular Probes 
Inc; Eugene, OR).  The cells were washed 2X in PBS and 1X in Triton-X PBS and mounted using 
VectaShield mounting medium (Vector Laboratories; Burlingame, CA).  Confocal microscopy was 
performed with a Leica TCS SP2 confocal microscope. 
 
3.6.5. Lentivirus Production and Transduction 
 
Lamin A-GFP and Progerin-GFP fourth generation replication-incompetent HIV-1-based lentivirus was 
produced using the ViraPowerTM Lentivirus Expression System following the manufacturer’s instructions 
(Invitrogen, Carlsbad, CA).  Briefly, 293FT cells were simultaneously transfected with ViraPower 
Packaging Mix and either GFP-LMNA or GFP-HGPS plasmids using Superfect transfection reagent 
(Invitorgen) according to the manufacturer’s instructions (The ViraPower Packaging Mix contains the 
necessary structural and replication components in trans on three separate plasmids.  The GFP-LMNA 
and GFP-HGPS plasmids contain elements that allow packaging of the gene constructs into virions.  The 
gene constructs are under the control of the ubiquitin promoter). Supernatant was collected 60 hours 
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post-transfection. The virus was concentrated via ultra-centrifugation at 50,000G for 3 hours.  Cells were 
transduced at an MOI of 20 for 18 hours. 
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CHATPTER THREE: SUMMARY AND CONCLUSIONS 
 
 
 
 
4.1.  Summary of results 
 
 
The aim of the research presented in this doctoral disseration was to investigate the molecular and 
cellular mechanisms contributing to the “premature aging” phenotype in HGPS.  Two approaches have 
been used to investigate such mechanisms.  One approach examined whether LMNA, the mutated gene 
in HGPS, is expressed in pluripotent ES cells in order to determine whether the adverse effects caused 
by Progerin begin during embryonic development.  The second approach examined whether DSB repair 
is compromised in HGPS cells in order to determine whether impaired repair is a molecular mechanism 
that contributes to the accelerated aging phenotype. 
 
The research presented in Chapter One examined whether A-type and B-type lamins are expressed in 
undifferentiated mESCs and hESCs.  The results show that although lamins B1 and B2 are expressed in 
undifferentiated mESCs and hESCs, lamin A/C is not (Figures 3, 4, and 5).  However, lamin A/C 
expression is detected after in vitro differentiation of hESCs (mESC cells were not examined), indicating 
that as hESCs differentiate, lamin A/C expression is activated (Figure 8).  This is in accordance with other 
reports that have shown that although B-type lamins are present during mouse embryonic development, 
lamin A/C is not expressed until the latter half of development (Prather et al., 1991; Prather et al., 1989; 
Rober et al., 1989; Schatten et al., 1985; Stewart and Burke, 1987).  Similarly, lamin A/C is not expressed 
or expressed at low levels in undifferentiated EC cells (Peter and Nigg, 1991; Stewart and Burke, 1987).  
Altogether, these results suggest that lamin A is not expressed during early human embryonic 
  62
development, but is activated as cells differentiate.  Thus, Progerin is probably absent during early human 
development, but accumulates concomitantly with LMNA expression at later developmental stages at 
which point it may exert a detrimental effect on the developmental process and produce the 
developmental defects present in HGPS patients.  Furthermore, the fact that some tissues show 
developmental defects while others are spared may be due to different initiation of LMNA expression in 
different tissues.  Similarly, the onset of LMNA expression in different  tissues may influence the severity 
of the degenerative phenotype manifested by those tissues.  More experimentation is needed to fully 
elucidate the pathological role of Progerin during human development. 
 
The research presented in Chapter Two examines whether DSB repair is compromised in HGPS cells.  
First, examination of the steady-state level of DSBs showed that HGPS cells have a higher level 
compared to wildtype cells (Figure 10 and 15B).  Experiments examining the repair IR-induced DSBs 
showed that the elevated steady-state level of DSBs in HGPS cells is due at least partly to impaired DSB 
repair (Figure 10 and 15B).  HGPS cells exhibit impaired repair of DSBs within two hours of irradiation, 
indicating an early repair defect.  This early repair defect may be due to impaired localization of DSB 
repair factors to DSBs.  Colocalization experiments post-irradiation showed up to a two hour delay in the 
localization of the DSB repair factor NBS1 and MRE11 to a percentage of DSBs (Figure 14 and 15G,H).  
The observation that localization of these repair factors was not impaired across the board, but only to 
particular DSBs, suggests that the local environment may contribute to the mislocalization.  Further, 
whereas wildtpye cells return to the steady-state level of DSBs by 24 hours post-irradiation, HGPS cells 
still exhibit statistically significant higher numbers of IR–induced DSBs remaining at 24 and 48 hours post-
irradiation (Figure S2), indicating that HGPS cells have difficulty or are unable to repair particular IR-
induced DSBs.  The accumulation of such irreparable DSBs could certainly lead to the activation of DNA 
damage response pathways and subsequently to apoptosis or senescence.  
 
Both the elevated steady-state level of DSBs and the impaired DSB repair of IR-induced DSBs were 
reproduced in healthy cells when Progerin was expressed (Figure 12 and 15C), indicating that Progerin 
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produces these phenotypes in a dominant gain-of-function fashion, similar to other HGPS phenotypes 
(Goldman et al., 2004; Scaffidi and Misteli, 2005).  Accordingly, FTI-treatment, which has been shown to 
reduce progerin levels and improve nuclear morphology in HGPS cultures (Capell et al., 2005; Fong et 
al., 2006a; Glynn and Glover, 2005; Liu et al., 2006; Toth et al., 2005; Yang et al., 2006; Yang et al., 
2008), also improves the repair kinetics of DSBs post-irradiation (Figure 13B and 15E).  Although a 
decrease in the number steady-state DSBs was detected in HGPS cells after FTI treatment, the reduction 
was not statistically significant.  Possible explanations for this apparent discreptency are discussed in 
Chapter Two.  Further experimentation needs to be performed to verify whether or not FTI treatment can 
reduce the elevated steady-state level of DSBs in HGPS cells. 
  
Interestingly, the DSB repair defect correlates strongly with the abnormal nuclear morphology (Figure 10 
and 15E).  This correlation may or may not be mechanistically significant as it is possible that both 
phenotypes are independently caused by some Progerin-dependent mechanism.  However, if such a 
mechanistic link exists between the two phenotypes, it is possible that structural irregularities cause the 
DSB repair defect and elevated levels of DSBs since it is accepted that DSB repair requires not only 
enzymatic, but also structural components (Assenmacher and Hopfner, 2004; de Jager et al., 2004; 
Hopfner et al., 2001).  The mechanism through which structural irregularities may interfere with DSB 
repair is discussed in detail in Chapter Two.  Briefly, progerin-induced irregularities in local nuclear and/or 
chromatin structure could physically interfere with the proper formation of DSB repair complexes.  Such a 
scenario could render local regions of the nucleus unfavorable to DSB repair.  DSBs that randomly occur 
in such structurally unfavorable regions may experience delayed or incomplete repair.  Such a possibility 
is supported by the structural role the MRN repair complex is proposed to have during DSB repair 
(Reviewed in (Assenmacher and Hopfner, 2004; Williams et al., 2007)).  As discussed in the introduction, 
the MRN complex is believed to function as a tethering scaffold that holds the two chromosome ends at a 
DSB and/or the recombinational partner strand in the case of HR repair in close proximity and prevents 
their physical separation.  The observed delayed localization of MRE11 and phospho-NBS1 to DSBs in 
HGPS cells may result in physical separation of the chromosome ends at DSBs and prohibit repair.  Thus, 
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even though by two hours post-irradiation phospho-NBS1 and MRE11 were localized to a similar 
percentage of DSBs in HGPS and wildtype cells, the initial localization delay in HGPS cells may render 
those particular DSBs irreparable. 
 
 
 
4.2. MECHANISTIC HYPOTHESES FOR HGPS PATHOLOGY 
 
 
Several hypotheses have been proposed for the molecular and cellular pathogenesis in HGPS, and it is 
quite possible that the total pathological effect is due to a combination of these mechanisms working in 
concert.  Interestingly, particular tissues or cell types may be more susceptible to different mechanism 
which may contribute to the segmental nature of HGPS.  One possibility is that since lamin A mutations 
including the HGPS mutation result in loss of nuclear structural integrity (Lammerding et al., 2004), the 
lack of nuclear structural support leads to physical cellular damage which may result in loss of function or 
cell death.  Obviously, HGPS does not lead to complete failure of nuclear structural integrity, but resulting 
structural weakness may be sufficient to affect tissues that are consistently subjected to physical stress 
such as blood vessel walls.  Indeed, HGPS patients do display various vascular abnormalities (Reviewed 
in (Hennekam, 2006)) and the primary cause of death is due to complications associated with the rapid 
onset of atherosclerosis.  However, it is difficult to imagine how such a mechanism would explain the 
development of lypodystrophy and multiple other HGPS features that affect tissues which are not under 
significant physical stress.  To investigate this hypothesis further, it would be interesting to examine 
whether vascular endothelial cells expressing Progerin show any gene expression or functional 
differences compared to wildtype cells in response to various forms of physical force in vitro. 
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Another possible mechanistic hypothesis is that the accelerated aging phenotype in HGPS is due to gene 
expression changes.  In support of this hypothesis lamin A has been shown to interact with particular 
transcription factors, including MOK2 (Dreuillet et al., 2002) and SREBP1 (Lloyd et al., 2002), as well as 
with retinoblastoma (Rb), which is involved in regulating cell cycle arrest and apoptosis (Johnson et al., 
2004; Mancini et al., 1994; Ozaki et al., 1994). It is possible that lamin A influences the activity of these 
factors and that the HGPS mutation alters their activity and as a consequence gene expression.  This is 
an interesting possibility since it would suggest that any genes whose expression is specifically altered by 
the HGPS mutation may also contribute to physiologic aging.  Alternatively, mutation in lamin A which 
leads to nuclear lamin disorganization appears to negatively affect polymerase II mediated transcription, 
suggesting that a mutated form of LMNA may lead to global transcriptional changes (Spann et al., 2002).  
Indeed multiple gene array experiments have demonstrated global changes in gene expression, although 
the changes have not been very consistent across different experiments (Csoka et al., 2004b; Ly et al., 
2000; Park et al., 2001). This suggests that, with the exception of particular genes whose expression may 
be affected through modification of transcription factor activity, the HGPS mutation does not result in 
consistent changes to a cell’s genetic expression profile, instead having a stochastic affect on gene 
expression.  Since lamin A expression appears to be confined to differentiated cells, it has been proposed 
that one of the functions of lamin A is to maintain the differentiated state, that is to “lock” cells into tissue 
specific gene expression patterns when they become terminally differentiated, most likely though 
structural control of local as well as global chromatin organization.  Indeed, as previously discussed, 
mutations in LMNA including the HGPS mutation result in chromatin epigenetic changes that may occur 
due to structural alterations in the nuclear lamina and nuclear matrix and can influence gene expression.  
Thus, the premature aging phenotype may not be due to specific gene expression changes that mimic 
physiological aging, but may simply be due to stochastically altered expression that renders cells unable 
to fulfill the their tissue-specific functional roles or that may result in cellular death and that ultimately lead 
to tissue/organ degeneration and failure.  
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A third mechanistic hypothesis that has gained momentum recently proposes that DNA damage 
accumulation is responsible for the premature aging phenotype in HGPS.  This is a logical conclusion 
considering that DNA damage is believed to contribute to physiological aging.  Research form other 
laboratories along with the results presented here demonstrates that the steady-state level of DSBs is 
elevated in HGPS and that the elevated levels are due at least partly to impaired DSB repair.   The 
accumulation of DSBs may be sufficient to produce the elevated levels of DNA damage response 
pathways as well as the elevated levels of apoptosis and senescence that have been described in HGPS 
cells.  If this is the case, the accelerated aging phenotype observed in HGPS is simply due to the 
amplification of one of the central contributors to physiological aging, DNA damage accumulation.  
  
But how would these mechanisms, working alone or in concert, produce the accelerated aging phenotype 
in HGPS patients?  It is likely that all three result in cellular dysfunction and/or cell loss through increased 
apoptosis or senescence.   Such cellular loss would increase the cellular turnover rate and could exhaust 
regenerative stem cell pools prematurely.   It is commonly accepted that most, if not all, human tissues 
maintain cellular homeostasis through continual regeneration from tissue-specific stem cell pools.  It has 
even been hypothesized that functional loss of adult tissue-specific stem cell pools contributes to normal 
aging (Reviewed in (Rossi et al., 2008; Sharpless and DePinho, 2007)).  In HGPS, adult tissue-specific 
stem cell pools are expected to be under a higher pressure to maintain tissue homeostasis due to 
increased cell loss through apoptosis and senescence caused by compromised nuclear structural 
integrity, altered gene expression, and/or inefficient DSB repair.  The higher rate of tissue cellular 
depletion may be too great for the regenerative capacity of stem cell pools to cope with causing gradual 
tissue degeneration.  Alternatively, it has been shown that some and perhaps all adult tissue-specific 
stem cells have limited proliferative capacity.  An increased rate of tissue turnover in HGPS could exhaust 
the proliferative capacity of adult tissue-specific stem cell pools more quickly, at which point the tissue will 
undergo degeneration.  Lastly, the adult stem cell pools themselves may be directly affected by the DSB 
repair defect, resulting in stem cell loss.  This last possibility needs to be investigated further, since there 
are contradictory reports regarding the expression of lamin A in undifferentiated cells (Constantinescu et 
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al., 2006; Lourim and Lin, 1989a; Rober et al., 1989; Soutoglou and Misteli, 2008).  In light of these 
possible scenarios the segmental nature of HGPS can easily be attributed to tissue-specific differences in 
LMNA expression, rates of DSB formation, tissue turnover, and available adult stem cell pools. 
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